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Abstract 
• Chapter 1: A review of Shapiro reactions as a coupling strategy in natural 
product total synthesis.  The syntheses of lycoramine, galanthamine, yuehchukene 
analogues, ovalicin, studies toward the ingenol core, haemanthidine, pretazettine, 
tazettine, crinamine, Taxol, colombiasin A, elisapterosin B, the AB ring fragment of 
spongistatin 1 and 8-epipuupewhedione are discussed. 
 
 
 
 
• Chapter 2: The convergent total synthesis of the marine natural product 
norrisolide is described.  Both subunits, the hydrindane core and the norrisane side chain, 
are prepared in an asymmetric fashion through kinetic resolution and enantioselective 
cyclopropanation, respectively.  A Shapiro reaction couples the two fragments and a 
Peterson olefination installs the 1,1-disubstituted olefin.  
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• Chapter 3: Preliminary experiments to isolate the biological target of norrisolide 
through reductive alkylation and tritium labeling are investigated.  Further experiments 
are proposed to shed light on the primary norrisolide-protein interactions. 
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Chapter 1  
The Shapiro Reaction as a Fragment Coupling Strategy in 
Convergent Natural Product Total Synthesis 
 
1.1 Introduction 
Total syntheses are often optimized by designing a convergent route. A 
convergent synthesis frequently improves the overall yield of the synthesis and conserves 
precious intermediates. Ideal couplings will happen late in the synthetic strategy using 
advanced intermediates with high yield and high selectivities. However, for large 
molecules, individual fragments may also be prepared in a convergent fashion, further 
improving the efficiency of the synthesis.  Many methods exist for these fragment-
coupling reactions, with C-C bond formation among the most challenging.  
Syntheses commonly employ transition metal-mediated reactions for C-C bond 
formation that are both efficient and powerful.  The Shapiro reaction shares a similar 
disconnection to these reactions.  In many instances, the Shapiro reaction has advantages 
over transition metal-mediated reactions.  Purification is simplified; no metal catalysts or 
ligands need to be removed at the end of the reaction. Less forcing conditions are 
required, as the Shapiro reaction is usually carried out at low temperatures (at or below 
0 ºC), compared to the often elevated temperature of metal-mediated reactions.  Finally, 
the Shapiro reaction is more environmentally friendly, not relying on stoichiometric 
heavy metals (such as tin in the Stille reaction) or other toxic additives such as arsenic.  
1-2 
This review will examine convergent natural product total syntheses, including advanced 
studies toward natural products that employ the Shapiro reaction.  To highlight the power 
of the strategy in convergent synthesis, only syntheses that bring together major 
fragments of the natural product targets have been included. 
 
 
1.2 Background and History of the Shapiro Reaction 
In 1952 Bamford and Stevens reported the decomposition of toluene sulfonyl 
hydrazones.1  This initial reaction produced trace amounts of crotonic acid (1.2) from 1.1 
through reaction with sodium in hot ethylene glycol (Scheme 1.1).  Bamford and Stevens 
also reported that simpler ketones, such as acetone and cyclohexanone, could also be 
transformed to their phenyl sulfonyl hydrazones and treated under the same conditions to 
give propylene and cyclohexene, respectively. 
 Fifteen years later, Shapiro reported an improved procedure to provide the same 
transformation.2  Treatment of camphor tosylhydrazone (1.3) with at least two 
equivalents of methyl or n-butyl lithium in hexanes provided 2-bornene (1.8) in 
quantitative yield (Scheme 1.2).  This reaction was successful with a variety of simple 
                                                 
1 Bamford, W. R.; Stevens, T. S. J. Chem. Soc. 1952, 4735-4740. 
2 Shapiro, R. H.; Heath, M. J. J. Am. Chem. Soc. 1967, 89, 5734-5735. 
Scheme 1.1 Bamford and Stevens’ reaction of an arylhydrazone to form crotonic acid. 
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starting ketones, such as 2-methyl cyclohexanone and cholesterol derivatives.  To begin 
the reaction the amine is deprotonated with the alkyl lithium base to give 1.4, followed by 
formation of dianion 1.5.  Elimination of the sulfonyl group followed by loss of 
molecular nitrogen provides 1.7, which upon proton quench gives olefin 1.8.   
 Although yields to form proton-quenched olefins were high, attempts to trap the 
vinyl lithium intermediate with deuterium through a D2O quench were met with low 
deuterium incorporation, except in the case of the most sterically hindered substrates.  It 
was hypothesized that the vinyl carbanion could abstract a proton from ethereal solvents.3  
Changing the solvent to hexanes only slightly alleviated the problem, leading to the 
conclusion that the carbanion intermediate could also abstract an α-proton from another 
molecule of the starting tosylhydrazone.  This evidence is consistent with the success of 
the sterically hindered substrates. 
 Without a general method to trap a variety of electrophiles for a wide range of 
substrates the synthetic utility of the Shapiro reaction was limited.  Bond and coworkers 
                                                 
3 Shapiro, R. H.; Heath, M. J.  J. Org. Chem. 1974, 39, 2302-2303. 
Scheme 1.2 Shapiro reaction of camphor tosylhydrazone with alkyl lithium reagents.  
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found two solutions to this problem.  First, the use of tetramethylethylenediamine 
(TMEDA) as a cosolvent with hexanes allowed for high deuterium incorporation after 
quenching with D2O.
4   Secondly, changing from a tosylhydrazone to a 2,4,6-
triisopropylbenzene sulfonyl (trisyl) hydrazone greatly improved the reaction in many 
respects, due to increased steric bulk of the hydrazone.5 
 The additional bulk of the aromatic ring had many advantages.  The isopropyl 
groups block deprotonation of the aromatic ring.  In the past, excess base was added to 
the reaction to account for this side reaction; however the excess base would also alkylate 
the electrophile coupling partner.  Therefore, excess electrophile was often added as well.  
The side products from these excess reagents could sometimes be problematic to separate 
from the desired product.  Changing to the trisylhydrazone eliminated these challenges, 
making this reaction much more synthetically useful. 
 The trisylhydrazone diianion also decomposes much more readily to the vinyl 
lithium species.  This decreases the amount of time that the vinyl anion and the 
hydrazone with its labile α-proton are both present, thus increasing the desired 
                                                 
4 Stemke, J. E.; Bond, F. T. Tetrahedron Lett. 1975, 16, 1815-1818. 
Scheme 1.3 Shapiro reaction followed by benzaldehyde trap employing a trisylhydrazone. 
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incorporation of the electrophile.  Indeed, Bond saw that the reaction of 1.9 with two 
equivalents of n-BuLi at –78 ºC followed by warming to 0 ºC and treatment with 
benzaldehyde gave 1.11 in 60% yield with less than 5% of the other regioisomer (Scheme 
1.3).6   
 With these improvements, electrophiles can easily be coupled to the vinyl anion 
resulting from the treatment of trisylhydrazones with base, opening the door for a variety 
of coupling reactions in the realm of total synthesis. 
 
 
1.3 Syntheses of (±)-Lycoramine and (±)-Galanthamine 
The recent syntheses of (±)-lycoramine (1.16) (Scheme 1.4) and (±)-galanthamine 
(1.23) (Scheme 1.5) by the Tu group exemplify the use of the Shapiro reaction early in a 
synthetic effort.7,8  Both alkaloids feature a unique tetracyclic framework with interesting 
biological properties; galanthamine has been approved for treatment for Alzheimer’s 
disease.9 
 The synthesis of (±)-lycoramine (1.16) began with the tosylhydrazone 1.12.  
Treatment of the tosylhydrazone with n-butyl lithium in TMEDA followed by addition of 
TBS protected o-vanillin gave the allylic alcohol 1.13 in 75%, installing two of the four 
                                                                                                                                                 
5 Chamberlin, A. R.; Stemke, J. E.; Bond, F. T. J. Org. Chem. 1978, 43, 147-154. 
6 The regioselective deprotonation from the less hindered position is described in ref. 2.  For another look at 
this reactivity, see: Corey, E. J.; Lee, J.; Roberts, B. E.  J. Am. Chem. Soc. 1997, 38, 8915-8918. 
7 Hu, X.-D.; Tu, Y.-Q.; Zhang, E.; Gao, S.; Wang, S.; Wang, A.; Fan, C.-A.; Wang, M. Org. Lett. 2006, 8, 
1823-1825. 
8 Fan, C.-A.; Tu, Y.-Q.; Song, Z.-L.; Zhang, E.; Shi, L.; Wang, M.; Wang, B.; Zhang, S.-Y. Org. Lett. 
2004, 5, 4691-4694. 
9 Rainer, M.; Drugs Today, 1997, 33, 273-279. 
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rings present in the natural product.  Allylic alcohol 1.13 is also the key intermediate of 
the synthesis, undergoing a semipinacol rearrangement upon exposure to 
N-bromosuccinimide.  After this key connection was made the five-membered ring was 
closed and the aldehyde homologated through a two-step procedure, giving 1.15.  
Formation of the acyl bromide, treatment with dry methylamine and a modified Pictet-
Spengler reaction with formaldehyde gave a lactam intermediate, which was reduced 
with lithium aluminum hydride to give the natural product 1.16.   
 The total synthesis of  (±)-galanthamine (1.23) follows a similar path to that of 
(±)-lycoramine, starting with a similar tosylhydrazone (1.17).  A Shapiro reaction, again 
with TBS protected o-vanillin gave the key intermediate that underwent a semipinacol 
rearrangement to give 1.19.  A Wittig olefination followed by concomitant deprotection 
of the ketone and then protection of the aldehyde gives 1.20, installing three of the four 
rings present in the natural product.  Oxidation to the enone followed by 1,2-reduction 
Scheme 1.4 Tu’s synthesis of (±)-lycoramine starting with a Shapiro reaction 
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with L-Selectride gave allylic alcohol 1.21, which underwent subsequent aldehyde 
deprotection and acylation, giving 1.22.  Installation of the seven-membered ring was 
done analogous to that of (±)-lycoramine, yielding 1.23. 
 These two syntheses show the power of a Shapiro reaction utilized at the 
beginning of a total synthesis.  Two vital segments of the natural products were brought 
together to give the allylic alcohol functionality desired for the key synthetic step. 
 
 
Scheme 1.5 Tu’s synthesis of (±)-galanthamine starting with a Shapiro reaction 
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1.4 Synthesis of (±)-Haemanthidine, (±)-Pretazettine, (±)-Tazettine and 
(±)-Crinamine from a common intermediate 
 Another example of an early stage Shapiro reaction from the Tu group that brings 
together the bulk of the carbon framework is in the syntheses of (±)-haemanthidine 
(1.32), (±)-pretazettine (1.33), (±)-tazettine (1.34) (Scheme 1.6) and (±)-crinamine B 
(1.36) (Scheme 1.7) by the Tu group.10  The syntheses of all four natural products began 
with a Shapiro reaction between 1.24 and piperonal (1.25), giving secondary alcohol 
1.26, which contains most of the carbons present in the natural products.  A semipinacol 
rearrangement promoted by NBS gave 1.27, installing the difficult to access quaternary 
center. 
 Addition of cyanide to the aldehyde, reduction with lithium aluminum hydride 
and protection with acetone gave 1.28.  Elimination of the bromide with DBU was 
followed by deprotection of the N,O-acetal and the ketal under acidic conditions. The 
deprotection unmasks an enone which was then attacked by the free amine.  Boc 
protection of the resulting secondary amine gave 1.29.   
Generation of the enone 1.30 took three steps.  TMS protection of the free alcohol 
was followed by formation of the enol ether and finally reaction with palladium acetate 
installed the enone.  Enone 1.30 underwent a 1,2-reduction with L-Selectride, and was 
protected as the methyl ether with inversion of stereochemistry.  The TMS ether was then 
deprotected and replaced with an acetate group.  Finally, Boc deprotection and 
formylation gave 1.31.  
                                                 
10 Zhang, F.-M.; Tu, Y.-Q.; Liu, J.-D.; Fan, X.-H.; Shi, L.; Hu, X.-D.; Wang, S.-H.; Zhang, Y.-Q. 
Tetrahedron, 2006, 9446-9445. 
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From 1.31 the first natural product, (±)-haemanthidine (1.32), was formed through 
reaction with phosphorus oxychloride followed by acetate deprotection.  The second 
natural product, (±)-pretazettine (1.33), was formed from 1.32 by reaction of methyl 
iodide in methanol followed by treatment with acid.  Methylation of the amine and 
opening of the hemiaminal was followed by ring closing to the lactol, giving 1.33.  For 
the third natural product, (±)-tazettine (1.34), 1.33 is treated with sodium hydroxide in 
Scheme 1.6 Tu’s syntheses of haemanthidine, pretazettine and tazettine from a 
common intermediate. 
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methanol to give the hemiacetal through a Cannizzaro reaction. 
To access the fourth natural product, (±)-crinamine B (1.36), the path diverges 
from the other natural products at ketone 1.30 (Scheme 1.7).  From 1.30, a Luche 
reduction of the ketone followed by methylation of the resulting allylic alcohol gave 35.  
Deprotection of the Boc and TMS groups followed by a Pictet-Spengler reaction with 
formaldehyde yields (±)-crinamine B.  The syntheses of these four natural products are an 
example of how the Shapiro reaction employed early in synthetic routes can bring 
together large carbon frameworks that can be functionalized to provide a variety of 
different natural product targets from a common intermediate. 
 
 
1. 5 Synthesis of Yuehchukene Analogues 
Yuehchukene (1.38), an indole alkaloid natural product with anti-implantation 
activity, was first isolated in 1985; the first total synthesis was completed the same year.11  
The first total synthesis by Cheng was a biomimetic dimerization (Scheme 1.8); however 
                                                 
11 Kong, Y.-C.; Cheng, K.-F.; Cambie, R. C.; Waterman, P. G. J. Chem. Soc., Chem. Commun. 1985, 47-
48. 
Scheme 1.7 Synthesis of (±)-crinamine B from common intermediate 1.30. 
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it suffered from the drawback that the dimerization step was low yielding.12  In addition, 
attempting to synthesize analogues with alternate substituents at C7 was not possible with 
this route, with most attempts not giving any desired product.13 
In order to access a series of analogues an early stage Shapiro reaction was 
                                                 
12 Cheng, K.-F.; Kong, Y.-C.; Chan, T.-Y. J. Chem. Soc., Chem. Commun. 1985, 48-49. 
13 Cheng, K.-F.; Chan, T.-Y.; Wong, T.-T.; Lai, T.-F. J. Chem. Soc., Perkin Trans. 1 1990, 1555-1562. 
Scheme 1.8 Cheng’s biomimetic synthesis of yuehchukene. 
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Scheme 1.9 Synthesis of two yuehchukene analogues. 
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utilized (Scheme 1.9).14  Hydrazone 1.40 was accessed from the corresponding ketone, 
treated with n-BuLi and added to aldehyde 1.39, giving 1.41 in 74% yield. This Shapiro 
reaction installed the carbon framework for the upper part of the molecule.  The resulting 
secondary alcohol was obtained in a 1:1 diastereomeric ratio; however oxidation with 
manganese dioxide to ketone 1.42 eliminated the stereogenic center.  This ketone 
underwent the key Nazarov cyclization to close the five-membered ring, resulting in 1.43.  
The ketone was reduced with lithium aluminum hydride and the resulting alcohol was 
condensed with either indole or 2-methylindole, giving 1.45 or 1.46, respectively.  
Removal of the phenyl sulfonyl protecting group with sodium amalgam gave 1.47 and 
1.48, both with the correct relative stereochemistry. 
 In addition to analogues 1.47 and 1.48, Cheng and coworkers made an 
enantiomerically pure camphor derivative 1.50 and a simplified t-butyl analogue 1.51.15,16  
                                                 
14 a) Cheng, K.-F.; Chan, K.-P.; Synth. Commun. 1990, 20, 3069-4076. b) Chan, K.-P.; Lai, T.-F. J. Chem. 
Soc., Perkin Trans. 1, 1991, 2461-2461. 
15 Cheng, K.-F.; Chan, K.-P.; Kong, Y.-C.; Ho, D.-D. J. Chem. Soc., Perkin Trans. 1, 1991, 2935-2939. 
Figure 1.1 Yuehchukene analogues made via Shapiro coupling reactions. 
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The syntheses of these analogues began with hydrazones 1.49 and 1.51, respectively.  
They both follow a path nearly identical to that of analogues 1.47 and 1.48 with minimal 
changes of reagents.   
 From these investigations and SAR studies the Cheng group found that the 
simplified analogue 1.52 has comparable potency to both the natural product and the 
more complex analogues.  In addition, the synthesis of analogue 1.50 helped to determine 
the absolute configuration of the natural product, showing similar potency while ent-1.50 
showed no activity.  These studies show the generality of the Shapiro reaction and how it 
can be used to access a variety of related structures quickly and in good yields.   
 
 
1.6 Synthesis of (-)-Ovalicin 
Many groups have undertaken the synthesis of the natural product ovalicin, using 
a variety of synthetic methods such as cycloadditions17 and carbohydrate chemistry.18  A 
common method of installing the olefinic side chain uses the Shapiro reaction.18,19  The 
efforts of the Samadi group, shown in Scheme 1.10, were the first to fully incorporate the 
coupling of the side chain directly from vinyl lithium 1.58.20 
                                                                                                                                                 
16 Cheng, K.-F.; Cao, G.-A.; Yu, Y.-W. Synth. Commun. 1994, 24, 67-75. 
17 Tiefenbacher, K.; Arion, V. B.; Mulzer, J. Angew. Chem. Int. Ed. 2007, 46, 2690-2693. 
18 Yadav, J. S.; Sreedhar, P.; Srihari, P.; Sarma, G. D.; Jagadeesh, B. Synthesis, 2008, 1460–1466.x.x.208. 
19 For other syntheses with similar incorporations of the olefinic side chain to that in Scheme 1.10 see: a) 
Corey, E. J.; Guzman-Perez, A.; Noe, M. C. J. Am. Chem. Soc. 1994, 116, 12109-12110. b) Yamaguchi, J.; 
Toyoshima, M.; Shoji, M.; Kakeya, H.; Osada, H.; Hayashi, Y.  Angew. Chem. Int. Ed. 2006, 45, 789-793. 
c) Hua, D. H.; Zhao, H.; Battina, S. K.; Lou, K.; Jimenez, A. L.; Desper, J.; Perchellet, E. M.; Perchellet, J.-
P.; Chian, P. K. Bioorg. Med. Chem. 2008, 16, 5232-5246. 
20 a) Bath, S.; Billington, D. C.; Gero, S. D.; Quiclet-Sire, B.; Samadi, M. J. Chem. Soc., Chem. Commun. 
1994, 1495-1496. b) Barton, D. H. R.; Bath, S.; Billington, D. C.; Gero, S. D.; Quiclet-Sire, B.; Samadi, M. 
J. Chem. Soc., Perkin Trans. 1, 1995, 1551-1558. 
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 The synthesis began from 1.53, which the Samadi group accessed from 
L-quebrachitol in 8 steps.  The enone was hydrogenated, which also afforded benzyl 
deprotection.  The more reactive α-alcohol was then benzoyl protected and the remaining 
free alcohol was protected as the TES ether. Wittig olefination of the ketone also resulted 
in benzoyl deprotection, giving 1.54.  Epoxidation of the exocyclic olefin with m-CPBA 
and oxidation of the free secondary alcohol gave the key intermediate 1.55.   
 To generate the side chain, a protocol developed by the Corey group21 was used.  
While the Corey group did use this synthon in the synthesis of ovalicin, they first trapped 
it with tributyltin chloride to give the vinyl stannane, which was then used in a separate 
step.   
                                                 
21 a) Corey, E. J.; Dittami, J. P. J. Am. Chem. Soc. 1985, 107, 256-257. b) Corey, E. J.; Lee, J.; Roberts, B. 
E. Tetrahedron Lett. 1997, 38, 8915-8918. 
Scheme 1.10 Total synthesis of (-)-ovalicin employing a Shapiro reaction to append 
the side chain. 
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Acetone trisylhydrazone (1.56) was treated with two equivalents of n-BuLi and 
kept at -78 ºC to generate the diianion.  The carbanion was reacted with prenyl bromide 
to give 1.57.  One equivalent of sBuLi was added to regenerate the carbanion and then 
the reaction was warmed to 0 ºC to facilitate loss of nitrogen and generate the vinyl 
lithium 1.58.   
 Keto epoxide 1.55 was then added to vinyl lithium 1.58. Approach of the 
nucleophile from the less hindered face gave tertiary alcohol 1.59 as the sole product in 
75% yield.  Epoxidation of the side chain was followed by deprotection of the TES group 
and oxidation with PDC gave the natural product (-)-ovacilin, 1.60.  This synthesis 
highlights the ability of the Shapiro reaction in constructing sterically hindered molecules 
through the generation of a quaternary center. 
 
 
1.7 Improved Access to the Ingenol Core 
 To date there have been three total syntheses of the natural product ingenol (1.61) 
by Winkler,22 Kuwajima23 and Wood.24  While these syntheses are very impressive for 
the efforts they entailed, they all have one common thread; all three are long, linear 
syntheses ranging from 35 to 46 steps.25   
                                                 
22 Winkler, J. D.; Rouse, M. B.; Greaney, M. F.; Harrison, S. J.; Jeon, Y. T. J. Am. Chem. Soc. 2002, 124, 
9726-9728. 
23 Tanino, K.; Onuki, K.; Asano, K.; Miyashita, M.; Nakamura, T.; Takahashi, Y.; Kuwajima, I.  J. Am. 
Chem. Soc. 2003, 125, 1498-1500. 
24 Nickel, A.; Maruyama, T.; Tang, H.; Murphy, P. D.; Greene, N. Y.; Wood, J. L.  J. Am. Chem. Soc. 
2004, 126, 16300-16301.  
25 For a review of these syntheses and other approaches, see: Cha, J. K.; Epstein, O. L. Tetrahedron, 2006, 
62, 1329-1343. 
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The Cha group developed a convergent approach to a simplified ingenol core with 
intentions of elaborating their work to a total synthesis (Scheme 1.11).26  
Retrosynthetically, ingenol can be simplified to 1.62 (where X is an alkyl or alkenyl 
group) through a 1,2-alkyl shift.  In turn, 1.62 can come from 1.63 after removal of the 
TBS group, oxidation and olefination followed by ring closing olefin or enyne 
metathesis.  The coupling of two advanced fragments, 1.64 and 1.65 through a Shapiro 
reaction will help to quickly construct the core. 
In order to rapidly determine the strength of their retrosynthetic analysis, the Cha 
group decided to test their route with a simplified variant of 1.65 in a Shapiro reaction 
with 1.64 (Scheme 1.12).  Starting from ketone 1.6627 deprotonation and trap with methyl 
iodide led to 1.64.  A Shapiro reaction with simplified coupling partner 1.67 provided the 
coupled product 1.68 in 80% yield and a three step sequence of TBAF deprotection, 
oxidation and olefination gave the diene 1.69.  A ring closing metathesis successfully 
generated 1.70, which is close to providing the simplified core. 
                                                 
26 Epstein, O. L.; Cha, J. K.; Angew. Chem. Int. Ed. 2005, 44, 121-123. 
27 For preparation of 1.49 from (+)-3-carene, see: Paquette, L. A.; Ross, R. J.; Shi, Y. S. J. Org. Chem. 
1990, 55, 1589-1598. 
Scheme 1.11 The Cha group’s Retrosynthesis of ingenol. 
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 Completing the synthesis of the core required separating the diastereomers of 
1.70.  Once a diastereomerically pure 1.70 was accessed, two steps transformed it into the 
core structure 1.72 (Scheme 1.13).  Olefin 1.70 was first treated with t-BuOOH-
VO(acac)2 providing the regioselectively epoxidized 1.71, which was then treated with 
AlMe3 at low temperatures inducing the 1,2-alkyl shift.  1.72 is a simplified version of 
the ingenol core, 1.62.  Structures similar to 1.62 have previously been elaborated to 
ingenol.  With the proper coupling partners, the Shapiro reaction has the potential to 
drastically shorten the route to ingenol. 
Scheme 1.12 Cha’s test substrate approach to the ingenol core. 
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Scheme 1.13 Completion of the simplified ingenol core. 
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1.8 Nicolaou’s Total Synthesis of Taxol 
 Taxol (1.73), a diterpene isolated from the bark 
of the pacific yew tree, is a very important natural 
product in the area of cancer therapy.  It has been in use 
in the US as a breast and ovarian cancer drug since 
1993.28  In the late 1980s and early 1990s many laboratories were active in trying to 
achieve the first total synthesis of Taxol.  In 1994 Holton and Nicolaou published almost 
simultaneous reports.  The Holton group published a linear approach starting from 
patchino.29   
The Nicolaou group approached Taxol in a convergent fashion, with the intention 
of connecting the A and C rings and then forming the B ring, followed by later 
installation of the D ring and the side chain.30   
Nicolaou’s synthetic efforts toward the A ring began with converting 1.74 into 
diene 1.76 for use in a Diels-Alder reaction (Scheme 1.14).  Ketone 1.74 underwent 
methyl Grignard addition followed by elimination of the resulting tertiary alcohol gave 
1,1-disubstituted olefin 1.75. The ethyl ester 1.75 was subjected to DIBAL reduction and 
acetate protection of the ensuing primary alcohol.  With diene 1.76 in hand, a Diels-Alder 
cycloaddition with 2-chloroacrylonitrile gave 1.77 with the desired regiochemistry.  The 
                                                 
28 Rowinksy, E. K.; Onetto, N.; Canetta, R. M.; Arbuck, S. G. Semin. Oncol. 1992, 19, 646-662. 
29 Holton, R. A.; Somoza, C.; Kim, H-B.; Liang. F.; Biediger, R. J.; Boatman, P. D.; Shindo, M.; Smith, C. 
C.; Kim, S.; Nadizadeh, H.; Suzuki, Y.; Tao, C.; Vu, P.; Gentile, L. N.; Liu, J. H. J. Am. Chem. Soc. 1994, 
116, 1597-1598. 
30 a) Nicolaou, K. C.; Nantermet, P. G.; Ueno, H.; Guy, R. K.; Couladouros, E. A.; Sorensen, E. J. J. Am. 
Chem. Soc. 1995, 117, 624-633. b) Nicolaou, K. C.; Liu, J.-J. Yang, Z.; Ueno, H.; Sorensen, E. J.; 
Claiborne, C. F.; Guy, R. K.; Hwang, C.-K.; Nakada, M.; Nantermet, P. G. J. Am. Chem. Soc. 1995, 117, 
634-544. c) Nicolaou, K. C.; Yang, Z.; Liu, J.-J.; Nantermet, P. G.; Claiborne, C. F.; Renaud, J.; Guy, R. 
K.; Shibayama, K. J. Am. Chem. Soc. 1995, 117, 645-652. d) Nicolaou, K. C.; Ueno, H.; Liu, J.-J.; 
Nantermet, P. G.; Yang, Z.; Renaud, J.; Paulvannan, K.; Chadha, R. J. Am. Chem. Soc. 1995, 117, 653-659.  
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acetate group of 1.73 was removed and replaced with a TBS group and the ketone was 
converted to the trisylhydrazone.  This completed the synthesis of the A ring synthon and 
sets up a Shapiro reaction to couple ring A to ring C. 
Prior to deciding on the Shapiro reaction as a coupling strategy the Nicolaou 
group also looked into using a Stille coupling.  While they were able convert ketone 1.78 
into a vinyl triflate and then the vinyl stannane, they were not successful with coupling to 
an appropriately functionalized C ring.  Simple couplings, such as with benzoyl chloride 
gave positive results; therefore, it was postulated that the steric hindrance of the gem-
dimethyl group on 1.79 impeded the Stille coupling with more sterically demanding 
substrates.  Therefore, Nicolaou decided on the Shapiro reaction for coupling the two ring 
systems and set out to synthesize a suitably functionalized C ring. 
 To begin the synthesis of the C ring, a Diels-Alder reaction between 1.80 and 
pyrone 1.81 was performed (Scheme 1.15).  To overcome the inherent regioselectivity of 
the reaction, Nicolaou employed a procedure developed by the Narasaka group that 
Scheme 1.14 Nicolaou’s synthesis of the A ring of Taxol. 
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temporarily tethers the allylic alcohol of 1.80 and the enol ether of 1.81.31  This 
temporary tether gave the regioselectivity shown in 1.82 after decomplexation of the 
boronic ester with neopentyl glycol.   
The strained 1.82 spontaneously rearranged under the reaction conditions, giving 
1.83.  Attempted protection of the free alcohols with TBSOTf resulted in addition of the 
secondary alcohol to the lactone followed by protection of the tertiary alcohol and the 
new orthoester.32  Reduction of the ethyl ester with lithium aluminum hydride gave the 
primary alcohol 1.84.  Treatment of 1.84 with CSA deprotected the lactol TBS group and 
gave back the lactone and free secondary alcohol.  TBDPS protection of the primary 
alcohol gave 1.85.  Benzyl protection of the secondary alcohol was followed by 
exhaustive reduction of the lactone with concomitant deprotection of the TBS group to 
give triol 1.86.  The triol was treated with CSA and 2,2-dimethoxypropane to initially 
                                                 
31 Narasaka, K.; Shimada, S.; Osoka, K.; Iwasawa, N. Synthesis 1991, 1171-1172. 
32 For a correction on the structure from the original paper see: Nicolaou, K. C.; Liu, J.-J.; Yang, Z.; Ueno, 
H.; Sorensen, E. J.; Claiborne, C. F.; Guy, R. K.; Hwang, C.-K.; Nakada, M.; Nantermet, P. G. J. Am. 
Chem. Soc. 1995, 117, 8690. 
Scheme 1.15 Nicolaou’s synthesis of a C ring synthon. 
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give a seven-membered acetal incorporating the two primary alcohols; however, after 
extended exposure to the reaction conditions rearrangement to the more 
thermodynamically stable five-membered acetal took place.  Oxidation of the remaining 
free alcohol to the aldehyde with TPAP/NMO gave aldehyde 1.87, the C ring synthon 
necessary for a Shapiro coupling with the A ring synthon. 
 To couple 1.79 and 1.87 through a Shapiro reaction 1.79 was first treated with 
n-BuLi generating the vinyl anion (Scheme 1.16). Aldehyde 1.87 was added, giving the 
secondary alcohol 1.88.  The resulting diastereoselectivity is hypothesized to come from 
a lithium chelate between the aldehyde and acetal, which blocks re face addition of 
carbanion nucleophile.  From 1.88 the new trisubstituted olefin was epoxidized 
diastereoselectively and the epoxide opened with lithium aluminum hydride to give 
tertiary alcohol 1.89.  This new diol was protected as the carbonate upon treatment with 
KH and phosgene.  The two silyl groups were deprotected and the resulting primary 
alcohols were oxidized with TPAP/NMO, giving dialdehyde 1.90.  The key McMurray 
coupling of 1.90 using titanium trichloride and zinc-copper couple gave an optimized 
yield of 25% for diol 1.91, completing the synthesis of the core structure of Taxol.  This 
core structure was elaborated to the natural product (1.73) in 17 steps.30d  The coupling of 
these two fragments highlights the utility of the Shapiro reaction in sterically hindered 
settings where transition-metal mediated couplings are not successful. 
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1.9 Total Synthesis of (-)-Colombiasin A and (-)-Elisapterosin B 
 (-)-Colombiasin A (1.105) and (-)-elisapterosin B (1.103) (Scheme 1.18) were 
isolated from Pseudopterogorgia elisabethae and quickly became of interest to the 
synthetic community.  Several total syntheses have been completed since 2001.33 In 2005 
the Harrowven group approached the synthesis of these two molecules in a convergent 
fashion, using a Shapiro reaction to bring together two fragments in preparation for a key 
Moore rearrangement.34  
The synthesis began with the reduction of ketone 1.92 (Scheme 1.17) with LAH 
                                                 
33 a) Nicolaou, K. C.; Vassilikogiannakis, G.; Mägerlein, W.; Kranich, R. Angew. Chem. Int. Ed. 2001, 40, 
2482-2486.  b) Nicolaou, K. C.; Vassilikogiannakis, G.; Mägerlein, W.; Kranich, R. Chem. Eur. J. 2001, 7, 
5359-5371.  c)Kim, A. I.; Rychnovsky, S. D. Angew. Chem. Int. Ed. 2003, 42, 1267-1270. d) Waizumi, N.; 
Stankovic, A. R.; Rawal, V. H. J. Am. Chem. Soc. 2003, 125, 13022-13023.  e) Boezio, A. A.; Jarvo, E. R.; 
Lawrence, B. M.; Jacobsen, E. N. Angew. Chem. Int. Ed. 2005, 44, 6046-6050.  f) Davies, H. M. L.; Dai, 
X.; Long, M. S. J. Am. Chem. Soc. 2006, 128, 2485-2490. 
34 Harrowven, D. C.; Pascoe, D. D.; Demurtas, D.; Bourne, H. O. Angew. Chem. Int. Ed. 2005, 44, 1221-
1222. 
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Scheme 1.16 Shapiro coupling between A and C ring synthons and completion of the 
Taxol core structure. 
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followed by hydroboration of the 1,1-disubstituted olefin, giving diol 1.93.  The primary 
alcohol was converted to the tosylate, which was then displaced with sodium cyanide.  
The nitrile was reduced to the aldehyde with DIBAL, giving homologated product 1.94.  
The aldehyde was subjected to a Julia-Kocienski olefination, yielding the new 
1,1-disubstituted olefin 1.96 in a 1:3 ratio of E:Z isomers which were carried forward as a 
mixture.  The secondary alcohol was then reoxidized to the ketone and the E:Z isomers 
were resolved through equilibration with iodine giving the desired E isomer 1.97 
exclusively.   
 The authors then wanted to append the squarate 1.98 to the cyclohexene moiety 
using a Shapiro reaction; however, isolation of the trisylhydrazone of 1.97 was not 
possible.  It was found that although they could form the hydrazone, it decomposed upon 
standing at room temperature.  Generation of the trisylhydrazone and then cooling of the 
reaction mixture followed by addition of n-BuLi and then squarate 1.98 gave a 36% yield 
Scheme 1.17 Shapiro coupling and preceding steps in Harrowven’s synthesis of 
(-)-colombiasin A and (-)-elisapterosin B. 
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of the desired tertiary alcohol 1.95 as a mixture of diastereomers, along with some of the 
proton quenched product.   
 With the coupled product in hand, the key Moore rearrangement was investigated 
(Scheme 1.18).  Squarate 1.99 was heated to 110 ºC under microwave heating conditions, 
giving an elecrocyclic ring opening to ketene 1.100.  This ketene in turn underwent an 
electrocylization followed by tautomerization, yielding bis-phenol 1.101.  Upon exposure 
to air 1.102 was oxidized to quinone 1.102, in 80% yield from 1.99.  Treatment of 1.102 
with borontrifluoride etherate removed the tBu protecting group and induced a [5+2] 
cycloaddition, giving (-)-elisapterosin B (1.103).  Quinone 1.102 can also be heated to 
150 ºC under microwave heating, giving Diels-Alder product 1.104, which was converted 
Scheme 1.18 Completion of the syntheses of (-)-colombiasin A and (-)-elisapterosin B 
via a Moore rearrangement. 
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to (-)-colombiasin A (1.105) after removal of the tBu protecting group with 
borontrifluoride etherate.   
 These syntheses are a good example of how a Shapiro reaction can be utilized 
later in the synthetic pathway to bring together larger fragments, providing a product that 
has all of the necessary carbons in place.  This allows for a rapid increase in complexity 
in the synthetic scheme, one of the most beneficial aspects of a convergent synthesis. 
 
 
1.10 Synthesis of the AB Ring Fragment of Spongistatin 1 
Spongistatin 1 (1.106) is an complex natural product comprised of a 42-membered 
macrolide framework with two spiroketals.  To date a variety of groups have worked on 
the total synthesis of this molecule and also that of spongistatin 2 (dechloro-
spongistatin 1).35  The Smith group published an initial total synthesis in 2001,36 and in 
2002 followed up with an improved synthesis of the ABCD ring fragment.37   
Retrosynthetic analysis of spongistatin (Scheme 1.19) shows that the natural 
product can be split roughly in half through an olefination and a macrolactonization.  The 
ABCD ring fragment section in turn can be broken down further through an aldol 
                                                 
35 a) Hayward, M. M.; Roth, R.; Duffy, K. J.; Dalko, P. I.; Stevens, K. L.; Guo, J.; Kishi, Y. Angew. Chem. 
Int. Ed.  1998, 37, 192-196. b) Evans, D. A.; Trotter, B. W.; Côté, B.; Coleman, P. J.; Dias, L. C.; Tyler, A. 
N. Angew. Chem. Int. Ed. 1997, 36, 2744-2747. c) Paterson, I.; Chen, D. Y.-K.; Coster, M. J.; Aceña, J. L.; 
Bach, J.; Gibson, K. R.; Keown, L. E.; Oballa, R. M.; Trieselmann, T.; Wallace, D. J.; Norcross, R. D. 
Angew. Chem. Int. Ed. 2001, 40, 4055-4060. 
36 a) Smith, A. B.; Doughty, V. A.; Lin, Q.; Zhuang, L.; McBriar, M. D.; Boldi, A. M.; Moser, W. H.; 
Murase, N.; Nakayama, K.; Sobukawa, M. Angew. Chem. Int. Ed. 2001, 40, 191-195.  b) Smith, A. B.; Lin, 
Q.; Doughty, V. A.; Zhuang, L.; McBriar, M. D.; Kerns, J. K.; Brook, C. S.; Murase, N.; Nakayama, K. 
Angew. Chem. Int. Ed. 2001, 40, 196-199. 
37 Smith, A. B.; Doughty, V. A.; Sfouggatakis, C.; Bennet, C. S.; Koyanagi, J.; Takeuchi, M. Org. Lett. 
2002, 4, 783-786. 
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disconnection.  The AB ring fragment is further divided with a three component coupling 
reaction between 1.109, 1.110 and 1.111.  Epoxide 1.109 is provided via Shapiro reaction 
of 1.112 and 1.113.   
To begin the synthesis of the AB ring fragment (Scheme 1.20), allylic alcohol 1.114 
underwent a Sharpless asymmetric epoxidation followed by protection of the primary 
alcohol, giving 1.115.  Opening of the epoxide with a vinyl cuprate and protection of the 
resulting secondary alcohol as the Boc carbonate gave 1.116.  Iodocarbonate cyclization 
of 1.116 led to 1.117 with good syn selectivity.  Methanolysis gave deprotection of the 
carbonate and concomitant epoxide formation, providing 1.112.  
 To continue the synthesis, fragment 1.120 was synthesized starting from methyl 
Scheme 1.19 Retrosynthesis of Smith’s second generation synthesis of spongistatin 1. 
O
O
O
O
O
O
O
O
O
Cl
OH
H
H
H
OH
H
H
HO
Me
OH H
OMe
HO
Me
OAc
Me
Me
H
MeO
OH
OH
Me
A
B
C
D
E
F
1.106
O
O
O
O
O
O
OTIPS
O H
H
OH
H
OMe
HO
Me
OAc
Me
Me
H
MeO
A
B
C
D
O
O
OTIPS
O
H
OH
O
Me
Me
H
MeO
A
B
1.107
1.108
NapO
O
OTES
S S
TES
OPMB
O Me
OTES
Me
OOH
BPSO
Me
OPMB
NNHTris
Me
1.110
1.109
1.111
1.113
1.112
olefination
lactonization
aldol
1-27 
ester 1.118 (Scheme 1.21).  PMB protection of the primary alcohol followed by Weinreb 
amide formation and methyl Grignard addition gave methyl ketone 1.119.  This ketone 
was transformed in good yield to the trisylhydrazone 1.120 in preparation for a Shapiro 
coupling.  The trisylhydrazone was treated with n-BuLi and then epoxide 1.112 was 
added, giving diol 1.121 in good yield.  Deprotection of the TBDPS group followed by 
epoxide formation gave key intermediate 1.109.   
Next in the synthetic pathway was the key three component coupling.  Lithiated 
TES-dithiane 1.110 was added to epoxide 1.111.  A Brooke rearrangement ensued and 
then epoxide 1.109 was added, resulting in diol 1.122.  Deprotection of the dithiane 
protecting group also served to deprotect the TES groups and gave the spiroketalization 
necessary for the AB ring system.  This product was then treated with acetic anhydride to 
protect the free secondary alcohol, giving 1.123.  The tertiary alcohol was protected as 
the TES ether and a transfer hydrogenolysis removed the naphthyl protecting group on 
the primary alcohol, providing 1.124.  Oxidation of the free alcohol to the aldehyde with 
Dess-Martin periodinane was followed by further oxidation to the carboxylic acid.  TIPS 
protection of the acid gave 1.125.  Deprotection of the PMB group and oxidation to the 
Scheme 1.20 Synthesis of epoxide 1.112 for the AB ring fragment of spongistatin. 
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aldehyde gave the AB ring fragment 1.126, which is identical to the fragment used in 
Smith’s earlier total synthesis of spongistatin.  Use of the Shapiro reaction to form this 
fragment allowed for the synthesis of the ABCD ring fragment in 15 fewer steps than in 
the previous synthesis. 
 
 
Scheme 1.21 Completion of the AB ring fragment of spongistatin. 
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1.11 Formal Total Synthesis of 8-Epipuupewhedione from (R)-(-)-Carvone 
8-epipuuphehedione (1.127) is the C8 epimer of puuphehedione, 
a marine sponge metabolite.  The C8 epimer displays a greater degree 
of activity against tumor cell lines 388, A-549, HT-29 and MEL-28.38  
The Banerjee group reported a formal total synthesis of 
8-epipuuphehedione from (R)-(-)-carvone (1.131), utilizing a late-stage 
Shapiro reaction.39 
 The total synthesis began with the synthesis of the aromatic portion of the 
molecule (Scheme 1.22).  Starting from the commercially available sesamol (1.128), 
                                                 
38 a) Barrero, A. F.; Alvarez-Manzandeda, E. J.; Chahboun, R. Tetrahedron Lett. 1997, 38, 2325-2328.  b) 
Barrero, A. F. Alvarez-Manzandeda, E. J.; Chahboun, R.; Cortés, M.; Armstrong, V. Tetrahedron, 1999, 
55, 15181-15208. 
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allylation and bromination gave 1.129 in excellent yield.  Bromide 1.129 was converted 
to aldehyde 1.130 by lithium halogen exchange and trap with DMF in preparation for the 
Shapiro coupling.   
 To assemble the decalin portion of the molecule, 1.131 was treated with LDA and 
the resulting enolate trapped with methyl iodide.  This new compound was again treated 
with LDA and the enolate trapped with 2,3-dibromopropane, giving 1.132 
diastereoselectively.  Treatment of the vinyl bromide with trifluoroacetic acid gave the 
decalin system as a mixture of olefin regioisomers.  This mixture of olefin isomers 
underwent a palladium catalyzed hydrogenation, which also reduced the α,β-unsaturated 
olefin and the bromide.  Ketone 1.133 was then transformed into the tosylhydrazone in 
good yield and treated with n-BuLi at low temperatures to generate the vinyl anion.  
Aldehyde 1.130 was added and the reaction yielded a mixture of unstable allylic alcohol 
1.134 and desired diene 1.135.  The allylic alcohol can be transformed into the diene 
through treatment with silica gel in methylene chloride, giving 1.135 in good yield from 
the hydrazone.  Treatment of 1.135 with rhodium trichloride removed the allyl protection 
group and induced cyclization to 1.136, which constitutes a formal total synthesis of 8-
epipuupehedione.  The natural product can be accessed in one step from 1.136 by 
oxidation with DDQ and TsOH in refluxing dioxane.38b  This synthesis exemplifies the 
use of the Shapiro reaction as a late stage coupling tool.  Both ring fragments are highly 
functionalized and once brought together the synthesis is nearly complete. 
 
                                                                                                                                                 
39 Maiti, S.; Sengupta, S.; Gtiri, C.; Achari, B.; Banerjee, A. K. Tetrahedron Lett. 2001, 42, 2389-2391. 
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1.12 Conclusion 
These fifteen examples of the Shapiro reaction being used to couple two fragments 
of a molecule during natural product total synthesis have shown a wide range of utility 
for this reaction.  Used early in the synthesis, the Shapiro reaction can easily bring 
together two simple fragments that can be elaborated into a vast array of final structures.  
Used later in the synthesis a Shapiro reaction can bring together more advanced 
intermediates, often setting up the key step of the synthesis.  Used at the end of the 
synthesis, the Shapiro reaction allows for two highly functionalized synthons to be joined 
with high functional group compatibility.   
 In all, the Shapiro reaction is often overlooked in favor of the more popular 
transition metal-mediated coupling reactions; however, it is a simple and effective 
method of coupling molecules together, especially in the context of natural product total 
synthesis. 
 
 
 
 
 
 
 
 
2-32 
Chapter 2  
Total Synthesis of Norrisolide 
 
2.1 Introduction 
 
 Norrisolide (2.1) is a marine natural product that was 
isolated from the nudibranch mollusc Chromodoris norrisi in 1983.1  
Structural determination was done by X-ray crystallography and 
proton NMR experiments.  Norrisolide has also been isolated as a 
minor component from other nudibranch molluscs. Along with 
norrisolide, three other compounds were isolated from Chromodoris 
norrisi: macfarlandin E (2.2), polkyhaphin A (2.3) and shahamin C (2.4) (Figure 2.1).2 
 In addition to being isolated from molluscs, norrisolide has also been isolated in 
minor amounts from sponges in the same area.  In light of this fact, it has been 
                                                 
1 Faulkner, D. J.; Hochlowski, J. E. J. Org. Chem. 1983, 48, 1141-1142. 
2 Bozbin, S. C.; Faulkner, D. J. J. Org. Chem. 1989, 54, 3902-3907. 
Figure 2.1 Other compounds isolated from Chromodoris norrisi. 
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hypothesized that the molluscs acquire the precursor to norrisolide and related 
compounds through feeding on the sponges.3  The general precursor to these diterpenes is 
believed to be the unknown compound spongiane (2.5).  More evidence supporting this 
theory is that several compounds related to the spongiane skeleton have been isolated 
from marine sponges that are taxonomically similar to those that have been shown to 
contain rearranged diterpene natural products.  Examples of these compounds4 are shown 
in Figure 2.2 and include aplysillin5 (2.6), isoagotholactone6 (2.7), aplyroseol-1 (2.8), 
aplyroseol-14 (2.9), aplyroseol-167 (2.10) and spongian-16-one8 (2.11).  
                                                 
3 Carmely, S.; Cojocaru, Y. L.; Kashman, Y. J. Org. Chem. 1988, 53, 4801-4807. 
4 For a review of spongiane diterpenoids in both intact and rearranged forms see: González, M. A. Curr. 
Bioact. Compd., 2007, 3, 1-36. 
5 Kazlaukas, R.; Murphy, P. T.; Wells, R. J. Tetrahedron Lett. 1979, 903-906. 
6 Cimino, G.; De Rosa, D.; De Stefano, S.; Minale, L. Tetrahedron 1974, 30, 645-649. 
7 Taylor, W.; Toth, S. Aust. J. Chem. 1997, 50, 895-902. 
8 Kernan, M. R.; Cambie, R. C.; Bergquist, P. R. J. Nat. Prod. 1990, 53, 724-727. 
Figure 2.2 Compounds containing the spongiane skeleton. 
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The proposed biosynthesis of norrisolide from 2.5 (Figure 2.3) involves a ring 
contraction to form the 6-5 ring system followed by a ring opening that forms the upper 
ring system of the 2.12.1,9 It is also possible to access the core structure of the 
macfarlandins and the dendrillolides from 2.5 starting from a ring expansion of the 6-
membered ring on the left, followed by a similar ring opening as above to access the 7-5 
ring system with the exocyclic olefin in 2.13.10  Many of these compounds have been 
isolated together, giving more weight to the proposed biosynthesis.  
There are many compounds that share the same oxygenated side chain as 
norrisolide.  Dendrillolides A (2.14) and E (2.15) (Figure 2.4) were originally isolated 
from Dendrilla sp.;11 however, structural reassignment occurred after subsequent 
                                                 
9 It is likely that oxidation of unactivated 2.5 occurs prior to rearrangement to the carbon skeleton of 
norrisolide. 
10 Faulkner, D. J.; Sullivan, B. J. Org. Chem. 1984, 49, 3204-3206. 
11 Sullivan, B.; Faulkner, D. J. J. Org. Chem. 1984, 49, 3204-3206. 
Figure 2.3 Proposed biosynthesis of norrisolide and related diterpene natural 
products. 
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isolation from Chromodoris macfarlandi in 1989.12  Also isolated from C. macfarlandi 
was macfarlandin C (2.16).  While other members of the macfarlandin family, such as 
macfarlandins D and E have shown antimicrobial activity, macfarlandin C was inactive 
against all bacteria tested.13 Spongionellin (2.17) was first reported in 1986 and was 
isolated from the sponge Spongionella gracilis in the Mediterranean Sea. 
There are a variety of compounds that share norrisolide’s 5-6 hydrindane ring 
system (Figure 2.5).  Chelonoplysin (2.18), and the cheviolenes C (2.19) and E (2.20) 
were isolated from the marine sponge Chelonaplysilla violacea.14  The hydrindane 
portions of all three molecules were identified by comparison to norrisolide.  Norrlandin 
(2.21) was so named since it resembles a hybrid of norrisolide and macfarlandin E. 
The chromodorolides A (2.22),15 B (2.23)16 and C (2.24)17 can be found in the 
same aplysillid sponge.  The chromodorolides have shown significant cytotoxicity 
                                                 
12  Bobzin, S. C Faulkner, D. J. J. Org. Chem. 1989, 54, 3902-2907. 
13 Molinki, T. F.; Faulkner, D. J.; Cun-Heng, H.; Van Duyne, G. D.; Clardy, J. J. Org. Chem. 1986, 51, 
4564-4567. 
14 Bergquist, P. R.; Bowden, B. F.; Cambie, R. C.; Craw, P. A.; Karuso, P.; Poiner, A. Taylor, W. C. Aust. 
J. Chem. 1993, 46, 623-632. 
15 Dumdei, E. J.; Dilip de Silva, E.; Andersen, R. J. J. Am. Chem. Soc. 1989, 111, 2712-2713. 
16 Morris, S. A.; Delip de Silva, E.; Andersen, R. J. Can. J. Chem. 1991, 69, 768-771. 
17 Rungprom, W.; Charvasiri, W.; Kokpol, U.; Kotze, A.; Garson, M. J. Mar. Drugs 2004, 2, 101-107. 
Figure 2.4 Natural products containing the norrisane side chain. 
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against the P388 mouse leukemia cell line.  In addition, chromodorolide A has shown 
antimicrobial and nematocidal activity.17  To the best of our knowledge other than 
norrisolide, it appears that no total synthesis of any of these molecules has been 
successfully completed.  
Early biological activity reported for norrisolide includes secretary phospholipase 
A2 (SPLA2) inhibition,
18 ichthyotoxicity19 and cyctotoxicitiy.20  At a concentration of 
2 µg/mL, norrisolide exhibits 66% inactivation of SPLA2.  Norrisolide was tested in a 
screen of compounds all containing a masked 1,4-dialdehyde moiety.  Ichthyotoxicity 
was studied in a mosquito fish assay and was found to be toxic at 10 ppm.  In this study, 
                                                 
18 Potts, B. C. M.; Faulkner, D. J.. J. Nat. Prod. 1992, 55, 1701-1717. 
19 Gavagnin, M.; Vardaro, R. R.; Avila, C.; Cimino, G. J. Nat. Prod. 1992, 55, 368-371. 
20 Rudi, A.; Kashman, Y. Tetrahedron 1990, 46, 4019-4022. 
Figure 2.5 Natural products containing the hydrindane ring system. 
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norrisolide was found to be concentrated along the mantle (the outer edge) of the mollusc 
and also in the digestive tract.  This finding helped strengthen the theory that norrisolide 
is a dietary metabolite. 
 Of particular interest to our lab was the biological activity first reported by 
Theodorakis in a report outlining a synthetic route to the norrisane side chain.21  
Theodorakis reported norrisolide irreversibly vesiculates the Golgi 
apparatus.  Our previous studies on ilimaquinone (2.26) had our lab 
interested in molecules that vesiculate the Golgi.22  Ilimaquinone 
reversibly vesiculates the Golgi by blocking new methylations in the 
cell.  Addition of SAMe to the cell can reverse the effects of 
ilimaquinone.  We were interested to learn if the biological target of norrisolide was 
related to that of ilimaquinone.   
The Theodorakis group reported the first total synthesis of norrisolide in 2004.23  
The complete synthesis has a longest linear sequence of 28 steps from commercially 
available material.  Starting from the Hajos-Parrish ketone 2.27, it takes three steps to 
install the gem-dimethyl group in 2.28 (Scheme 2.1). Reduction and Barton-McCombie 
deoxygenation gives 2.29, which in turn can undergo hydroboration to set the trans ring 
junction as a 2.5:1 (trans:cis) mixture of diastereomers.  Another Barton-McCombie 
deoxygenation provides 2.30.   Four steps consisting of deprotection of the TBDPS group 
with TBAF, PCC oxidation, hydrazone formation and reaction with iodine under basic 
                                                 
21 Kim, C.; Hoang, R.; Theodorakis, E. A. Org. Lett. 1999, 1, 1295-1297. 
22 Radeke, H. S.; Digits, C. A.; Casaubon. R. L.; Snapper. M. L. Chem. Biol. 1999, 6, 639-647. 
23 Brady, T. P.; Kim. S. H.; Wen, K.; Theodorakis, E. A. Angew. Chem. Int. Ed. 2004, 43, 739-742. 
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conditions gives the vinyl iodide 2.31, which is ready for coupling to the top half of the 
molecule.   
As shown in Scheme 2.2, synthesis of the norrisane side chain began from the 
Diels-Alder cycloaddition of 2.32 and 2.33 under Lewis-acid mediated conditions to give 
the 5-6 system as a single isomer.  DIBAL reduction of the lactone followed by oxidative 
cleavage of the olefin in the 6-membered ring gave 2.34.  The resulting lactol was 
protected as the methyl acetal and a series of six steps removed one carbon from the side 
Scheme 2.1 Theodorakis’ synthesis of a hydrindane intermediate. 
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Scheme 2.2 Theodorakis’ synthesis of the norrisane side chain. 
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chain to ultimately give 2.36 as the coupling partner for the top half of the molecule.  
This route improved upon a previous route from the same group that started from D-
mannose.21 
 Assembly of the two coupling partners went smoothly (Scheme 2.3).  Lithium-
halogen exchange of vinyl iodide 2.31 followed by addition to aldehyde 2.36 gave the 
allylic alcohol, which was oxidized to the enone and the olefin reduced under standard 
conditions to give 2.37 as a single diastereomer.  Methyl lithium addition followed by 
elimination gave the 1,1-disubstituted olefin in moderate yield.  To finish the synthesis, 
the acetoxy group must be installed.  This process began with silyl deprotection and 
oxidation of the resulting primary alcohol to the aldehyde (2.38).  Methyl addition and re-
oxidation gave the methyl ketone, which, after manipulation of the methyl acetal back to 
the lactone, was submitted to Bayer-Villager conditions to provide 2.1 in an overall yield  
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Scheme 2.3 The completion of Theodorakis’ synthesis of norrisolide. 
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of 0.68%.  It is important to note that at the beginning of our synthetic efforts these 
results were not yet published. 
 The Theodorakis group has also begun to investigate the biological activity24 of 
norrisolide, although finding a suitable molecule for the identification of norrisolide’s 
biological target has proven challenging.25,26 Through testing various analogues it was 
shown that the hydrindane portion of the molecule is necessary to achieve biological 
activity; however, it is also necessary to have an electrophilic component in the upper 
portion of the molecule to achieve irreversible fragmentation of the Golgi complex.  
These results will be discussed in further detail in the next chapter. 
 
 
2.2 Retrosynthetic Analysis  
 Our retrosynthetic plan starting from 2.1 brings us back through functional group 
manipulations and olefination to enone 2.39 (Scheme 2.4).  This enone can be 
synthesized from the coupling of nucleophile 2.42 with electrophile 2.40, which could 
take on the form of the aldehyde, acid halide or Weinreb amide. Electrophile 2.40 is 
accessed through the thermal rearrangement of cyclopropane 2.41, which in turn can 
come from known compounds.  Nucleophilic coupling partner 2.42 can be synthesized 
from the known ketone, which in turn can be brought back all the way to 2-methyl-2-
                                                 
24 Brady, T. P.; Wallace, E. K.; Kim, S. H.; Guizzunti, G.; Malhotra, V.; Theodorakis, E. A. Bioorg. Med. 
Chem. Lett. 2004, 14, 5035-5039.  For a full report of the synthesis, see: Brady, T. P.; Kim, S. H.; Wen, K.; 
Kim, C.; Theodorakis, E. A. Chem. Eur. J. 2005, 11, 7175-7190. 
25 Guizzunti, G.; Brady, T. P.; Malhotra, V.; Theodorakis, E. A. J. Am. Chem. Soc. 2006, 128, 4190-4191. 
26 Guizzunti, G.; Brady, T. P.; Malhotra, V.; Theodorakis, E. A. Bioorg. Med. Chem. Lett. 2007, 17, 320-
325. 
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cyclopenten-1-one (2.43).  This planned route generates a large degree of complexity 
with a minimum number of functional group manipulations. 
 
 
2.3 Synthesis of the Hydrindane Portion  
 When our lab began synthetic efforts towards norrisolide, the state of the art for 
synthesizing the hydrindane portion of the molecule was a route developed by the 
Paquette group for their synthesis of ent-grindelic acid.27  We were able to intersect this 
synthesis with intermediates known from our group’s synthesis of ilimaquinone (Scheme 
2.5).28   
                                                 
27 Paquette, L. A.; Wang, H-L. J. Org. Chem. 1996, 61, 5352-5357. 
28 Bruner, S. D.; Radeke, H. S.; Tallarico, J. A.; Snapper, M. L. J. Org. Chem. 1995, 60, 1114-1115. 
Scheme 2.4 Retrosynthetic analysis of norrisolide 
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 Starting from 2.44, lithium-ammonia reduction followed by trap with methyl 
iodide installed the gem-dimethyl compound 2.45, which is necessary for the carbon 
framework of norrisolide.  Wolff-Kishner reduction afforded 2.45, which underwent PCC 
oxidation to the ketone.  Bromination with pyridinium bromide perbromide followed by 
hydrolysis gave 2.46.  After a series of three steps, including ring opening through a lead 
tetraacetate cleavage, 2.46 is transformed to the dimethyl ester 2.47.  Dieckmann 
cyclization of 2.47 followed by decarboxylation gave 2.48 in a total of 10 steps from 
2.44.  While this route was sufficient for the initial investigative stage of our synthesis, 
we strove to streamline the route to 2.48, possibly through a ring-closing metathesis 
approach.   
 In that vein, work by the Lipshutz group outlining the conjugate addition of 
various allyl groups to cyclic enones29 tied nicely into our synthetic plan.  Taking the 
exact substrate from Lipshutz’s report, enone 2.43 can be alkylated with the cuprate of 
                                                 
29 Lipshutz, B. H.; Hackmann, C.; J. Org. Chem. 1994, 59, 7437-7444. 
Scheme 2.5 Our first-generation synthesis of 2.48. 
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prenyl Grignard 2.49 at –78 °C (Scheme 2.6).  We found that a modification of the 
procedure, including the use of HMPA as an additive,30 helped to increase the yield and 
reproducibility of obtaining the TMS enol ether as opposed to the deprotected ketone 
(which was Lipshutz’s ultimate desired product).   
Attempts to allylate the protected enolate in one pot were unsuccessful; however, 
treatment of the unpurified TMS enol ether (2.50) with methyl lithium at –15 ˚C followed 
by cooling and addition of HMPA and allyl bromide31 provided diene 2.51 in a 60% yield 
over two steps as a single diastereomer.  This sequence can be carried out on a multi-
gram scale.  With the diene in hand, ring closing metathesis (RCM) with 0.5 mol% 
Grubbs’ second generation catalyst (2.53) gives 2.52 in good yield, thus constructing the 
carbon framework for the hydrindane portion of the molecule in only three steps.  
Hydrogenation with palladium on carbon and slightly elevated hydrogen pressure (10 
atm) cleanly gives (±) 2.48 quantitatively without the need for further purification.   
Efforts to employ a one-pot tandem RCM/hydrogenation were unsuccessful 
without the addition of palladium on carbon before the hydrogenation took place.  Also, 
purification of 2.52 directly after RCM is more straightforward than after being taken on 
crude through the hydrogenation.  In addition, since (±)2.48 does not require purification 
after simple hydrogenation, we felt that there was no large advantage to optimizing the 
tandem process. 
                                                 
30 Williams, D. R.; Heidebrecht, R. W. Jr. J. Am. Chem. Soc. 2003, 125, 1843-1850. 
31 Cheung, A. K. Total syntheses of (+)- and (-)-Cacospongionolide B: investigation into structural 
requirements for phospholipase A2 inhibition.  Ph.D. Dissertation, Boston College, Chestnut Hill, MA, 
2003. 
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To access optically pure 2.48, it was necessary to perform a resolution.  In lieu of 
a traditional resolution approach, we decided to carry out a kinetic resolution using CBS 
reduction.  Using the proper antipode of the catalyst (2.54) should allow us to selectively 
reduce the undesired enantiomer of 2.48 while leaving the desired enantiomer at the 
ketone oxidation state.  Indeed, this is the case in our reaction.  Treatment of (±)-2.48 
with 10 mol% of (S )-(−)-2-methyl-CBS-oxazaborolidine (2.54) and 0.5 equivalents of 
borane-dimethylsulfide complex gives resolved 2.48 in 36% recovery.  The enantiomeric 
excess of this reaction typically ranges from 95% to 98% ee, giving an s value in the 
range of 8.5 to 14.5, where an s value of 10 is generally considered synthetically useful.32  
                                                 
32 Kagan, H. B.; Fiaud, J. C. Top. Stereochem. 1998, 18, 249-325. 
Scheme 2.6 Improved synthesis of ketone 2.48. 
Me
O
Me
Me
MgBr
+
CuBr⋅DMS, TMSCl
HMPA, THF, –78 °C;
Et3N, hexanes,
–78 °C
Me
OTMS
Me Me
i) MeLi, HMPA
THF, –15 °C → rt;
ii) Allyl bromide,
THF, –78 °C → rt,
12 h
60%
OMe
H
(±) 2.51
2.53
(0.5 mol%)
CH2Cl2, rt
12 h
80%
OMe
Me Me
H
(±) 2.52
H2 (10 atm)
Pd/C (5 mol%),
EtOAc, rt, 12 h
99%
OMe
Me Me
H
(±) 2.48
OMe
Me Me
H
2.54
(10 mol%)
0.5 equiv. BH3⋅SMe2
THF, 0 °C, 90 sec
36% recovered SM
>95% ee
Me Me
N B
O
Me
H
PhPh
2.43 2.49 2.50
2.48
NN
Ru
PCy3
Cl
Cl
Ph
2.53 2.54
2-45 
The alcohol product can be reoxidized with PCC and reduced with the opposite antipode 
of the CBS catalyst to give the opposite enantiomer of 2.48 if desired. 
 
 
2.4 Synthesis of the Norrisane Side Chain 
 While there are a handful of methods in the literature for synthesizing the 
tetrahydrofurofuranone ring system that is present in the upper portion of norrisolide, 
many were too lengthy or lacked the ability to easily introduce asymmetry.33  Ultimately, 
it was decided that a formal 1,3-dipolar cycloaddition between a diester diazo compound 
and a furan derivative would be the most efficient way to access our carbon framework.  
Work done by the Pirrung group was the starting point for this investigation.34  Pirrung 
showed that fused acetal products could be accessed in high yields starting from the 
cyclic diazo 2.55 (Scheme 2.7).  Reaction of 2.55 with furan gives cyclopropane 2.57, 
which spontaneously rearranges in situ to provide 2.58.   
                                                 
33 For a more in-depth look at formation of these fused acetal systems, along with early studies on the 
norrisane side chain in our group, see: Casaubon, R. L. The Golgi-Disrupting Agents Ilimaquinone and 
Norrisolide: Determination of Biological Interactions Through Synthesis.  Ph.D. Dissertation, Boston 
College, Chestnut Hill, MA, 2004. 
34 Pirrung, M. C.; Zhang, J.; Lackey, K.; Sternbach, D. D.; Brown, F. J. Org. Chem. 1995, 60, 2112-2124.  
 
Scheme 2.7 Pirrung’s synthesis of fused acetal systems. 
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 An early attempt at this type of reaction in our group was between diazo 2.59 and 
dihydrofuran (2.50) using catalytic rhodium acetate, as shown in Scheme 2.8.  This 
reaction demonstrated the fragmentation of the correct cyclopropyl bond, giving the 
desired product, as opposed to a ring opened olefinic compound.   
With the success of this test reaction, 2.60 was replaced with oxidized 2.62 
(Scheme 2.9).  What was obtained from the reaction of furanone 2.62 and diazo 2.59 was 
not, surprisingly, the fused acetal system.  It was determined that the product of the 
reaction was cyclopropane 2.41.  Cyclopropanes had not previously been isolated in these 
types of reactions.  However, it was postulated that the electron withdrawing nature of the 
lactone hindered the cleavage of the cyclopropane, therefore suppressing rearrangement. 
Rearrangement of the isolated cyclopropane can be induced thermally under 
dilute conditions.  Thermolysis of 2.41 in benzene [0.2 M] at 185 °C gives 2.63, which 
does not require further purification. Using this method, we can synthesize the carbon 
skeleton of the norrisane side chain in just two steps.  
Scheme 2.8 Synthesis of the desired carbon framework of the fused acetal ring system. 
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Scheme 2.9 Cyclopropanation and rearrangement to access the fused acetal system. 
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Access to an enantiomerically enriched norrisane side chain is necessary for our 
synthesis. Early attempts at using commercially available catalysts (Figure 2.6), such as 
Doyle’s catalyst 2.64 and Davie’s catalyst 2.66 gave low selectivities.  The BINOL-
derived catalyst 2.65 was more selective, giving 42% ee. 
After testing various chiral Rhodium catalysts, our best results were with Müller’s 
catalyst 2.68.35  We were able to obtain up to 70% ee on large scale by employing slow 
addition of the diazo compound to the reaction.  The selectivity of this reaction is 
determined by chiral HPLC after thermolysis to 2.63.  
 In addition to providing the best enantioselectivity for this reaction, catalyst 2.68 
also increases the rate of the reaction from 12 hours (for the racemic reaction with 
Rh2(OAc)4) to two hours.  This rate enhancement allows us to decrease the equivalents of 
2.62, which isomerizes into conjugation during the course of the reaction.  With a faster 
                                                 
35 Müller, P.; Allenbach, Y.; Robert, E. Tetrahedron: Asymmetry 2003, 14, 779-785. 
Figure 2.6 Comparison of chiral catalysts for asymmetric cyclopropanation, showing 
yields and selectivities for 2.63. 
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reaction, and therefore shorter reaction times, the isomerization is less of a factor, thus 
allowing us to use only 2.5 equivalents of 2.62 as opposed to four in the racemic reaction. 
Catalyst 2.68 is synthesized in two steps, beginning from t-leucine and 1,8-
naphthalic anhydride.  This adduct is then treated with rhodium acetate dimer with 
continuous removal of acetic acid through a Soxhlet extraction to provide 2.68 as a green 
solid that is air and moisture stable.  After cyclopropanation, the catalyst can be 
precipitated with acetonitrile with 85% recovery and used one more time for 
cyclopropanation with the same efficiency. 
As seen in Scheme 2.10, the synthesis continues with enantioenriched 2.63 being 
hydrogenated under 60 atm H2 to provide 2.69.  This reaction must be buffered with one 
equivalent of triethylamine to counteract the inherent acidity of the palladium on carbon 
catalyst.  This reaction occurs diastereoselectively to provide 2.69 with a syn relationship 
between all the hydrogens, introducing the cup-shaped ring system present in norrisolide. 
The lactone in 2.69 is reduced with DIBAL and transformed to the TBS acetal for 
protection from later chemistry, such as alkyl lithium and Grignard additions.  The 
Scheme 2.10 Elaboration of the norrisane side chain to Weinreb amide coupling partner. 
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reduction proceeds stereoselectively, with the hydride delivered solely from the top face 
of the molecule.  The lactol is not isolated, but is taken directly on to the protection 
reaction, which affords clean 2.70 in 50% over the two steps.  At this point, the methyl 
ester of 2.70 is transformed into the Weinreb amide, following the Merck procedure,36 
which is a suitable electrophile for fragment coupling.  Early attempts in our group to 
synthesize the acid (and the subsequent acid chloride) or the aldehyde were not 
successful. 
 
 
2.5 Fragment Coupling to Generate the Norrisolide Framework 
 To bring together the two ring system fragments, we decided to investigate a 
Shapiro coupling. To begin, we first needed to synthesize a suitable coupling partner 
from ketone 2.48 (Scheme 2.11).  Reaction with 2,4,6-triisopropylphenylsulfonyl 
                                                 
36 Williams, J. M.; Jobson, R. B.; Yasuda, N.; Marchesini, G.; Dolling, U.-H.; Grabowski, E. J. J. 
Tetrahedron Lett. 1995, 36, 5461-5464. 
Scheme 2.11 Transforming the hydrindane to a hydrazone for Shapiro coupling. 
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hydrazide under acid catalysis gave 2.72 in 72% yield after recrystallization and drying 
over P2O5.   
 Treatment of 2.72 with two equivalents of n-BuLi gave the vinyl anion 2.42 in 
situ, which was in turn added to Weinreb amide 2.71, giving enone 2.73 as a mixture of 
diastereomers stemming from the minor enantiomer from the cyclopropanation (Scheme 
2.12).  At this stage the diastereomers were not separable by chromatography and were 
taken on as a mixture through hydrogenation.  Hydrogenation of 2.73 was found to work 
best with rhodium on alumina as a catalyst, using ethyl acetate as solvent.  Methanol was 
also employed, but varying levels of water content occasionally caused epimerization α to 
the carbonyl.  At this stage that the diastereomers resulting from the minor enantiomer of 
2.71 were separated by silica gel chromatography. 
Scheme 2.12 Coupling of the two fragments and diastereoselective hydrogenation. 
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2.6 Olefination Studies 
 With 2.74 in hand, we needed to carry out the olefination of the bridging 
carbonyl.  This process proved to be much more difficult than initially expected.  
Theodorakis’ report was published just as we reached this step in our synthesis.  As seen 
in Scheme 1, his team used a two-step approach to access the 1,1-disubstituted olefin, 
through addition of methyl Grignard and then elimination with thionyl chloride, since 
traditional olefination methods were not successful.   
Efforts to use these conditions to olefinate 2.74 (Scheme 2.13) were not 
successful.  Methyl Grignard added cleanly to the ketone, providing 2.75 in quantitative 
yield.  However, attempts to eliminate water to form the 1,1-disubstituted olefin were 
unsuccessful.  The complex mixture of products appeared to contain some 
tetrasubstituted olefin resulting from elimination toward the norrisane side chain.  
Attempts to optimize this process through base screens and other parameters such as 
temperature, time, concentration and other dehydrating agents37 did not give satisfactory 
results. 
                                                 
37 Dehydration reagents designed to give the less substituted olefin, such as Martin sulfurane or Burgess 
reagent were unsuccessful, as these reagents afforded no reactivity even under forcing conditions. 
Scheme 2.13 Addition of methyl Grignard in attempts at a two-step olefination 
procedure. 
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Interestingly, studies on the opposite diastereomer (resulting from fragment 
coupling of the minor enantiomer of 2.71) did produce the desired 1,1-disubstituted 
enone.33   This seemingly unproductive pathway was, however, instrumental in being able 
to determine which enantiomer of cyclopropanation catalyst needed to be used to 
generate the correct cyclopropane enantiomer for the synthesis.  The diastereomer may 
also be useful for future biological studies. 
At this time, we decided to direct our attention to some one-pot olefination 
procedures.  Theodorakis had reported that Wittig and Julia olefinations were not 
successful for them, and indeed we found this to be the case in our hands as well.   
Typical crude reaction mixtures from these olefinations generally contained a mixture of 
the epimerized ketone and elimination of the methoxy group, giving 2.76 and 2.77, 
respectively, as shown in Scheme 2.14.  Both of these products are hypothesized to arise 
from the harsh basic nature of these reagents.  The carbonyl α proton in 2.74 is easily 
epimerized; simply leaving the compound at room temperature overnight results in minor 
amounts of the epimerized product. 
Scheme 2.14 Typical results from Wittig or Julia olefinations of 2.74. 
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We felt CH2(MgX)2
38
 was a promising reagent for a one-pot olefination, since 
methyl Grignard addition to 2.74 is a quantitative reaction.  While the reagent could be 
prepared and used to olefinate benzophenone in yields similar to the original report, no 
reaction was obtained in the desired reaction.  Using a similar concept of 
geminal dimetallic compounds, the reactive mixture of Zn/CH2Br2/TiCl4 
(the Takai olefination) has been used to rapidly and selectively olefinate 
compounds in studies on compounds in the gibberellin family.39  This 
reagent has also been reported in large-scale reactions40 and various methodologies.41 
Unfortunately, we again did not obtain any of the desired olefin.  
Another geminal dimetallic compound that is popular in methenylation chemistry 
is the Nysted reagent (2.78).42  The Nysted reagent has been used in Fürstner’s synthesis 
of the amphidinolides (Scheme 2.15).43  Ketone 2.79 turned out to be more sterically 
congested and less reactive than initially thought, and traditional olefination methods 
                                                 
38 Bertini, F.; Grasselli, P.; Zubiani, G. Tetrahedron 1970, 26, 1281-1290. 
39 Lombardo, L. Tetrahedron Lett. 1982, 23, 4293-4296. 
40 Lombardo, L. Org. Syn. 1987, 65, 81-85. 
41 a) Takai, K.; Kakiuchi, T.; Kataoka, Y.; Utimoto, K. J. Org. Chem. 1994, 59, 2668-2670. b) Matsubara, 
S.; Mizuno, T.; Otake, T.; Kobata, M.; Utimoto, K.; Takai, K. Synlett, 1998, 1369-1371. 
42 Matsubara, S.; Sugihara, M.; Utimoto, K. Synlett, 1998, 313-315. 
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Scheme 2.15 Fürstner’s use of the Nysted reagent in olefination of an advanced 
intermediate in the synthesis of amphidinolides. 
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were ineffective.  The researchers sought a method that would allow the reaction to take 
place at elevated temperature to increase the flexibility and conformation of the 
macrocycle to allow for the ketone center to become more sterically available.  Also, a 
method that avoided base was desired to avoid opening of the macrolactone.  The Takai 
olefination was successful for this reaction; however, the results were not consistent.  
Instead, the Nysted reagent with TiCl4 as a promoter gave 1,1-disubstited olefin 2.80 in 
64% yield.   Unfortunately, even given this precedent, the Nysted reagent did not affect 
the olefination of 2.74, resulting in no reaction even in refluxing THF. 
In 2004, the Lebel group published two reports outlining a rhodium-catalyzed 
methenylation using TMS diazomethane, of both aldehydes and ketones.44,45 This 
reaction does not require addition of base and is reported to be mild enough for sensitive 
and enolizable substrates.  Unfortunately, to olefinate aliphatic ketones, this reaction 
requires elevated temperatures, which ultimately epimerized the ketone, giving 2.76.   
Similar results were obtained with the Petasis reagent (Cp2TiMe2), which also does not 
require the addition of base but does require elevated temperatures to generate the 
reactive species.   
Investigations into the Peterson olefination46 started with addition of 
TMSCH2MgCl into the ketone 2.74 to give 2.81 in quantitative yields (Scheme 2.16).  
The more widely used, and commercially available, TMSCH2Li was not successful in 
                                                                                                                                                 
43 Aïssa, C.; Fiveiros, R.; Ragot, J.; Fürstner, A. J. Am. Chem. Soc. 2003, 125, 15512-15520. 
44 Lebel, H.; Guay, D.; Paquet, V.; Huard, K. Org. Lett. 2004, 6, 3047-3050. 
45 Lebel, H.; Paquet, V. J. Am. Chem. Soc. 2004, 126, 320-328. 
46a) Hudrlik, P. F.; Peterson, D. Tetrahedron Lett. 1972, 1785-1787. b) For a more in-depth discussion of 
this reaction, see: van Staden, L. F.; Gravestock, D.; Ager, D. J. Chem. Soc. Rev. 2002, 31, 195-200. 
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this reaction, even using the common and often necessary additive CeCl3.
47  These 
conditions resulted in decomposition of the starting material without producing any 
desired product.  Preparing the same reagent fresh did not have any effect on the outcome 
of the reaction. 
Attempts at elimination of 2.81 began with one of the most general procedures, 
simple treatment with KH in ethereal solvents, such as THF, diethyl ether and dioxane.  
These conditions did give trace amounts of desired product during one early attempt; 
however, these results were not reproducible.  Additives such as HMPA, TMEDA or 
crown ethers did not have any favorable influence on the reaction, nor did elevating the 
temperature.  Switching to NaH or KHMDS, other common bases for this reaction, also 
did not provide the desired product. 
Acidic conditions, from an early report by Peterson,46 using acetic acid saturated 
with sodium acetate only afforded deprotection of the TBS group.  Even continuing to 
push the reaction after this deprotection did not lead to any of the 1,1-disubstituted olefin.  
A review on methylenations48 brought to our attention an alternative elimination method 
                                                 
47 Johnson, C. R.; Tait, B. D. J. Org. Chem. 1987, 52, 281-283. 
48 Beadham, I.; Micklefield, J. Curr. Org. Syn. 2005, 2, 231-259. 
Scheme 2.16 Addition of TMSCH2MgCl to 2.74 as the first step in the Peterson 
olefination. 
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to complete the Peterson olefination transformation.  Treatment of the alkoxide, after 
addition of the Grignard or lithium reagent, with thionyl or acetyl chloride achieved the 
formation of methylenecyclohexene in quantitative yields from cyclohexanone, whereas 
acidic conditions isomerize the 1,1-disubsituted olefin into the ring.49   
Attempting these conditions, using acetyl chloride as a quench for the addition of 
TMSCH2MgCl did not produce any olefinic product, only 2.81.  This reaction was less 
clean than the standard reaction.  Independent deprotonation of 2.81 with KHMDS and 
subsequent treatment with AcCl produced a complex mixture of products, which 
contained a minor amount of the desired olefin.  Adding triethylamine or pyridine did not 
increase the amount of product produced, nor did it clean up the reaction mixture.  
Thionyl chloride in the place of acetyl chloride did not produce any desired product. 
However, replacing the acetyl chloride with triflic anhydride and using excess pyridine 
cleanly gave the 1,1-disubsituted olefin 2.83 as the only product (Scheme 2.17).   
With 2.83 in hand, we were able to continue in the synthesis, with the remaining 
steps all occurring on the periphery of the molecule, consisting of deprotection and 
                                                 
49 Chan, T. H.; Chang, E. J. Org. Chem. 1974, 39, 3264-3268. 
Scheme 2.17 Elimination to the 1,1-disubstituted olefin using triflic anhydride. 
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oxidation back to the lactone and manipulation of the methyl acetal by epimerization and 
acetylation. 
 
 
2.7 Studies on an Alternative Route to Install the 1,1-Disubstititued Olefin  
In addition to olefination, we also looked into installing the 1,1-disubstituted 
olefin before coupling the two fragments through a metal-catalyzed reaction.  We were 
able to make a variety of coupling partners, such as vinyl halides, triflates, stannanes and 
borates, as shown in Schemes 2.18 and 2.19.  
Ketone 2.48 can be elaborated to the vinyl triflate 2.84 through treatment with 
LDA and then Comins reagent (N-(5-chloro-2-pyridyl)triflimide)50 in 66% yield.  2.48 
can also be converted to vinyl halides through the hydrazone 2.85.  Treatment with 
elemental iodine or NBS gives vinyl iodide 2.86 and vinyl bromide 2.89, respectively.  
The vinyl iodide was further transformed to the stannane 2.88 through lithium-halogen 
exchange followed by trap with tributyltin chloride, giving a 2:1 mixture of desired 
product to proton-quenched product. The undesired product is simply removed by high 
vacuum, leaving the desired vinyl stannane behind in 42% yield.  Another cross-coupling 
partner, the vinyl trifluoroborate, can also be generated in 55% yield from 2.86 through 
lithium-halogen exchange followed by trapping with potassium bifluoride and water.  
2.87 is not stable enough for long-term storage, so it must be prepared fresh for each use. 
                                                 
50 Comins, D. L.; Dehghai, A. Tetrahedron Lett. 1992, 33, 6299-6302. 
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 To generate coupling partners for the norrisane side chain, we must begin by 
adding one carbon.  From 2.71, methyl Grignard is added in 88% yield.  This can then be 
elaborated to the vinyl triflate in conditions similar to above.  The triflate (2.90) can also 
be further converted to the vinyl stannane through Stille cross coupling conditions with 
hexamethylditin in 41% yield.   
 Unfortunately, all the cross coupling reactions tried between the hydrindane and 
norrisane portions were unsuccessful.  Negishi, Suzuki, and Stille couplings were all 
attempted, and all gave no reaction.  We were able to couple test reagents, such as phenyl 
trifluoroborate to 2.90, but no test couplings between the hydrindane coupling partners 
Scheme 2.18 Synthesis of coupling partners of the hydrindane portion of the molecule. 
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Scheme 2.19 Synthesis of the coupling partners of the norrisane portion of the molecule. 
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2.84, 2.86, 2.87, 2.88 or 2.89 were successful under thermal or microwave conditions.  
We have hypothesized that the ring junction methyl group imposes an intense steric 
hindrance to the cross coupling reaction.  However, at this time our olefination studies 
were improving, so it was determined that studies on this route were no longer necessary. 
 
 
2.8 Completion of the Synthesis 
 To complete our synthesis, once the 1,1-disubstituted olefin was installed, only 
three transformations remained.  To begin, we deprotected the TBS acetal of 2.83 
(Scheme 2.20) with TBAF buffered with acetic acid.  This lactol was not purified, but 
oxidized directly with PCC.  This gave the lactone 2.92 in 70% yield over two steps, 
leaving one final transformation. In earlier studies33 and in model studies, it was found 
that a mixture of acetic and trifluoroacetic acids could epimerize and install the acetate 
group necessary for the natural product.  Unfortunately, these conditions provided a 
mixture of epimers, the minor of which was determined to be norrisolide.   
Scheme 2.20 Deprotection and oxidation of the norrisane side chain. 
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We were able to complete this transformation by first hydrolyzing the methyl 
acetal to the lactol with a 3.3:1 mixture of trifluoroacetic acid to water gave a 1:1 mixture 
of lactol epimers (2.94) (Scheme 2.21).  Upon protection as the acetate using standard 
conditions gave only one compound in 40% yield over the two steps.  We identified this 
compound as 2.1, which matched spectral data with that of natural norrisolide. 
 
 
2.9 Conclusion 
 We have completed the total synthesis of norrisolide in a longest linear sequence 
of 13 steps, with an overall yield of 1.7%.  Our route improves on the previously 
published route to this molecule, using less than half the number of steps and doubling 
the overall yield.  This synthesis employs a rapid entry into the hydrindane core, along 
with access to the norrisane side chain without having to rely on the chiral pool.   
 
 
 
Scheme 2.21 Completion of the total synthesis of norrisolide. 
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2.10 Experimental and Supporting Information 
 
General Methods 
 Reagents were purchased from commercial suppliers and used without further 
purification, with the exception of the following: HMPA, TMSCl, Et3N, allyl bromide, 
acetic anhydride and ethyl acetate were distilled over CaH2.  Tetrahydrofuran, diethyl 
ether, dichloromethane and benzene were dried on alumina columns using a solvent 
dispensing system.  Hexanes was distilled prior to being used as a chromatography 
solvent. 
 Reactions were run in oven dried (140 °C, overnight) glassware under an inert 
atmosphere of dry nitrogen unless otherwise noted.  Liquids were transferred to the 
reaction flask via syringe through rubber septa.  All reactions were stirred with PTFE 
covered stirbars.  Air and moisture sensitive compounds were transferred in a glove box 
under nitrogen atmosphere.  Concentration refers to the removal of solvent using a Büchi 
rotary evaporator at 40 torr followed by a vacuum pump at 1 torr.  Base washed silica gel 
was prepared by washing with 1% Et3N in EtOAc or Et2O (depending on the eluent 
mixture of the column) followed by 100% EtOAc or Et2O and then equilibrating with the 
solvent mixture to be used for elution.  Cerium ammonium molybdate was used as the 
primary thin layer chromatography (TLC) staining reagent.  Silica gel column 
chromatography was performed using Baxter brand silica gel (60 Å, 230-240 mesh 
ASTM.) 
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 1H NMR spectra were commonly recorded on a Varian GN-400 (400 MHz) 
spectrometer, but in some cases a Varian Unity 300 (300 MHz) was used.  Chemical 
shifts are reported in ppm with the solvent resonance as the internal standard (CHCl3, δ 
7.26 ppm).  Data are reported as follows: chemical shift, multiplicity (s = singlet, d = 
doublet, t = triplet, q = quartet, m = multiplet) and coupling constant (Hz), and  
integration.  13C NMR were recorded on a Varian GN-400 (100 MHz) or a Varian 
Gemini-500 (125 MHz) spectrometer with complete proton decoupling.  Chemical shifts 
are reported in ppm with the solvent resonance as the internal standard (CHCl3, δ 77.2).  
Infrared (IR) spectra were obtained using Nicolet Avatar 360 Spectrophotometer, v max in 
cm-1.  High-resolution mass spectral analyses (HRMS) were performed using ESI+ or 
DART+ as the ionization technique.  Enantiomeric ratios were determined by chiral 
HPLC on a Shimadzu chromatograph with a Chiralcel OD column (4.6 x 250 nm) by 
Chiral Technologies (90:10 hexanes:isopropanol, detected at 230 nm) or by Chiral GC 
analysis Supelco Betadex 120 column (30 m x 0.25 mm).  Optical rotations were 
measured on a Rudolph Research Analytical Autopol IV polarimeter.     
 
Synthetic Procedures 
Diene 2.51: To a suspension of CuBr·DMS (16.28 g, 79.2 mmol) in THF 
(150 mL) at –78 ºC was added a solution of prenyl Grignard (440 mL, 
0.15 M in THF, 66.0 mmol) dropwise via cannula.  The reaction was 
allowed to stir at –78 ºC for 15 min.  HMPA (18.4 mL, 106 mmol) was then added, and 
the reaction was allowed to stir for an additional 20 min at –78 ºC. A solution of 2-
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methyl-2-cylopenten-1-one (5.2 mL, 52.8 mmol), TMSCl (13.4 mL, 106 mmol) and THF 
(25 mL) was then added over 2 h via syringe pump, and the reaction mixture was allowed 
to stir for an additional hour.  A solution of Et3N (16.2 mL, 116 mmol) in hexanes (60 
mL) was then added over 1 h via syringe pump.  The reaction was allowed to stir 1 h at 
-78 ºC and was then warmed to 0 ºC for 30 min.  The reaction was diluted with Et2O (400 
mL) and added to a cold 10% saturated solution of NH4Cl (600 mL) in a separatory 
funnel.  The layers were separated, and the organic layer was washed with portions of 
cold 10% saturated aqueous solution of NH4Cl (300 mL each) until the aqueous layer no 
longer turned blue.  The organic layer was then washed with brine, dried with MgSO4 
and concentrated.  The crude TMS enol ether (a yellow oil) was taken on immediately 
without purification.   
 To a solution of the enol ether (52.8 mmol) in THF (240 mL) at –15 ºC was added 
methyl lithium (38.5 mL, 1.37 M in Et2O, 52.8 mmol).  The reaction was allowed to stir 
and warm to room temperature over 1 h.  The reaction mixture was then cooled to  
–78 ºC and HMPA (36.8 mL, 211 mmol) was added.  After 15 min allyl bromide (23.0 
mL, 264 mmol) was added.  The reaction mixture was allowed to stir and warm to room 
temperature over 16 h.  The reaction was then treated with 1 M HCl (300 mL), allowed to 
stir for 5 min, and then diluted with Et2O (200 mL).  The layers were separated and the 
aqueous layer was extracted with Et2O (3 x 100 mL), dried with MgSO4, and 
concentrated.  The crude yellow oil was purified by silica gel chromatography (100% 
hexanes to 50:1 hexanes:Et2O) to provide the diene as a clear and colorless oil (6.8 g, 
62%). Rf =0.26 (10:1 hexanes:Et2O); IR (thin film) v max 3078, 2969, 2362, 2340, 1740, 
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1638, 1460, 1107, 998, 904 cm-1; 1H NMR (400 MHz, CDCl3, δ) 5.98 (dd, J = 17.6, 10.4 
Hz, 1H), 5.51 (dddd, J = 14.8, 10.4, 8.8, 6.0 Hz, 1H), 5.06-4.95 (m, 4 H), 2.50 (ddt, J = 
14.4, 6.0, 1.6 Hz, 1H), 2.40-2.27 (m, 2H), 2.08-1.91 (m, 3H), 1.76-1.68 (m, 1H), 1.15 (s, 
3H), 1.11 (s, 3H), 0.95 (s, 3H); 13C NMR (100 MHz, CDCl3, δ) 223.2, 147.4, 135.1, 
118.3, 111.0, 53.6, 50.2, 42.5, 39.7, 37.9, 27.8, 26.3, 21.3, 20.3; HRMS-DART (m/z) 
calcd for C14H23O [M
+] 207.1749, found 207.1755. 
 
Ketone 2.52: To diene 2.51 (5.47 g, 26.5 mmol) dissolved in CH2Cl2 (132 
mL) was added Grubbs’ second-generation catalyst (0.11 g, 0.13 mmol). 
The reaction was allowed to stir for 16 h open to air.  At the completion of 
the reaction silica gel (5 g) was added and the reaction was allowed to stir for an 
additional 30 min.  The reaction was then filtered and concentrated.   The resulting 
yellow oil was purified by silica gel chromatography (50:1 to 20:1 pentane:Et2O) to 
provide a volatile, pale yellow oil (3.9 g, 83%).  Rf = 0.56 (5:1 hexanes: Et2O); IR (thin 
film) v max 2957, 2913, 1737, 1464, 1065, 1029, 723 cm
-1; 1H NMR (400 MHz, CDCl3, 
δ) 5.53 (ddd, J = 10.0, 4.8, 2.8 Hz, 1H), 5.45 (dt, J = 10.0, 1.6 Hz, 1H), 2.46 (ddd, J = 
19.2, 8.4, 0.8 Hz, 1H), 2.13 (dd, J = 19.2, 9.6 Hz, 1H), 2.02 – 1.95 (m, 3H), 1.81 (dddd, J 
= 12.0, 11.4, 10.4, 9.4 Hz, 1H), 1.65 (dd, J = 13.2, 5.6 Hz, 1H), 1.04 (s, 3H), 1.03 (s, 3H), 
0.98 (s, 3H); 13C NMR (100 MHz, CDCl3, δ) 221.9, 138.2, 122.1, 51.4, 47.1, 36.1, 35.8, 
33.7, 31.7, 23.1, 19.8, 16.7; HRMS-DART (m/z) calcd for C12H19O1 [M
+] 179.1436, 
found 179.1431. 
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Hydrindane (±)-2.48: To a suspension of Pd/C (0.67 g, 10 wt%, 0.59 
mmol) in EtOAc (20 mL) in a bomb sleeve was added ketone 2.52 (2.1 g, 
11.8 mmol) in EtOAc (40 mL).  The reaction mixture was placed in a Parr 
bomb. The bomb was sealed, flushed with H2 and then pressurized to 10 atm H2.  After 
16 h with vigorous stirring the reaction mixture was filtered through celite with EtOAc 
(80 mL) to give the desired compound as a clear, colorless, volatile oil (2.05 g, 96%). Rf 
= 0.26 (10:1 hexanes:Et2O); 
1
H NMR (400 MHz, CDCl3, δ) 2.42 (ddd, J = 19.2, 9.2, 1.2 
Hz, 1H), 2.06 (dt, J = 18.0, 8.8 Hz, 1H), 1.88 (dddd, J = 12.0, 9.2, 5.6, 0.8 Hz, 1H), 1.8-
1.4 (m, 6H), 1.29 (dd, J = 13.2, 5.6 Hz, 1H), 1.14 (m, 1H), 0.94 (s, 6H), 0.87 (s, 3H). 
 
(+)-Hydrindane 2.48: To a solution of (S)-(−)-2-methyl-CBS-
oxazaborolidine (0.55 mL, 1 M PhMe, 0.56 mmol) in THF (27 mL) in a 1 
L round bottom flask at 0 ºC was added BH3·SMe2 (0.26 mL, 2.78 mmol).  
The reaction mixture was allowed to stir at 0 ºC for 15 min, at which time ketone (±)-2.48 
(1.0 g, 5.5 mmol) was added in THF (27 mL).  The reaction mixture was allowed to stir 
for 2 min at 0 ºC, then MeOH (20 mL) and 1 M HCl (20 mL) were added and the reaction 
mixture was warmed to room temperature and allowed to stir for 1 h.  Et2O (100 mL) was 
added and the layers separated.  The aqueous layer was extracted with Et2O (3 x 20 mL), 
and the combined organic layers were washed with brine (2 x 40 mL), dried with MgSO4 
and concentrated to give a crude white oil.   The crude compound was purified by silica 
gel chromatography (20:1 pentanes:Et2O elute the ketone, then 1:1 hexanes:Et2O to elute 
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the alcohol).  The ketone was provided as a clear, colorless, volatile oil (0.32 g, 32%).Rf 
= 0.26 (10:1 hexanes:Et2O); [α]D
20 = +49.9 (c 3.8, CH2Cl2); 
1
H NMR (400 MHz, CDCl3, 
δ) 2.42 (ddd, J = 19.2, 9.2, 1.2 Hz, 1H), 2.06 (ddd, J = 18.0, 8.8, 8.8 Hz, 1H), 1.88 (dddd, 
J = 12.0, 9.2, 5.6, 0.8 Hz, 1H), 1.8-1.4 (m, 6H), 1.29 (dd, J = 13.2, 5.6 Hz, 1H), 1.14 (m, 
1H), 0.94 (s, 6H), 0.87 (s, 3H). 
2.48 Racemic Standard 
2.48 Enantioenriched through CBS reduction 
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Cyclopropane 2.41: To rhodium catalyst 2.68 (0.86 g, 0.59 mmol) 
was added PhF (30 mL) and furan-2(3H)-one (5.2 mL, 74 mmol).  A 
solution of dimethyl 2-diazomalonate (4.0 mL, 29 mmol) in PhF (20 
mL) was added to the reaction mixture over 2 h via syringe pump.  
The reaction mixture was allowed to stir for an additional hour after the addition, at 
which time the reaction was concentrated.  The resulting thick green oil was added 
dropwise to CH3CN (400 mL), where the catalyst precipitated as a purple solid.  This was 
filtered and concentrated.  The crude light green oil was purified by base washed silica 
gel chromatography (2:1 hexanes:Et2O) to give the product as a yellow oil (4.36 g, 70%). 
Rf = 0.43 (1:1 hexanes:EtOAc); [α]D
20 = -51.5 (c 1.60, CH2Cl2); IR (thin film) v max 
3073, 3008, 2870, 2851, 1589, 1469, 1423, 1042, 722, 698, 598 cm-1; 1H NMR (400 
MHz, CDCl3, δ) 4.78 (d, J = 6.4 Hz, 1H), 3.78 (s, 3H), 3.76 (s, 3H), 3.08 (dd, J = 19.0, 
0.8 Hz, 1H), 2.92 (dd, J = 19,0, 6.8 Hz, 1H), 2.54 (ddd, J = 7.2, 6.4, 0.8 Hz, 1H). 13C-
NMR (100 MHz, CDCl3, δ) 175.0, 167.1, 164.4, 63.5, 53.4, 37.5, 29.7, 25.8; HRMS-ESI 
(m/z) calcd for C9H11O6 [M
+] 215.0556, found 215.0560.  
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2.41 Racemic Standard 
2.41 from Enantioselective Cyclopropanation 
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Dihydrofurofuranone 2.63: Cyclopropane 2.41 (0.40 g, 1.86 
mmol) was dissolved in benzene (100 mL) and placed in a 350 mL 
heavy walled pressure vessel.  The vessel was sealed and heated to 
185 ºC for 24 h, at which time the reaction mixture was allowed to cool to room 
temperature.  The reaction mixture was then concentrated to give a light tan solid that 
was used without further purification (3.25 g, 82%).  Rf = 0.21 (1:1 hexanes:EtOAc); 
[α]D
20 = +30.5 (c 0.40, CH2Cl2);  IR (thin film) v max 2953, 1797, 1713, 1679, 1645, 
1472, 1396, 1282, 1269, 1088, 974 cm-1; 1H NMR (400 MHz, CDCl3, δ) 6.28 (d, J = 6.8 
Hz, 1H), 4.01 (m, 1H), 4.00 (s, 3H), 3.70 (s, 3H), 2.85 (d, J = 2.8 Hz, 2H); 13C NMR 
(100 MHz, CDCl
3
, δ) 174.0, 165.3, 164.4, 103.5, 79.4 58.0, 51.2, 41.7, 33.7; HRMS-
DART (m/z) calcd for C9H11O6 [M
+] 215.0555 found 215.0564; m.p. 108 – 112 °C. 
 
Tetrahydrofurofuranone 2.69: Pd/C(0.79 g, 10 wt%, 0.78 mmol) 
was weighed into a bomb sleeve.  EtOAc (20 mL) and Et3N (1.1 
mL, 7.84 mmol) were added, followed by ester 2.63 (1.7 g, 7.84 
mmol) in EtOAc (20 mL).  The reaction mixture was placed into a Parr bomb, which was 
sealed, flushed with H2 and pressurized to 60 atm with H2.  The reaction mixture was 
allowed to vigorously stir for three days at room temperature, at which point the reaction 
was judged to be complete by 1H NMR of an aliquot.  The reaction mixture was filtered 
through celite with EtOAc (100 mL) and concentrated.  The crude oil was purified on a 
base washed silica gel column (2:1 hexanes:EtOAc) to give an oil (1.1 g, 63 %) that 
solidified upon freezing (–20 ºC).  Rf = 0.41 (1:1 hexanes:EtOAc); [α]D
20 = –9.6 (c 0.25, 
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CH2Cl2); IR (thin film) v max 3008, 2953, 2844, 1784, 1738, 1442, 1358, 1236, 1177, 
1067, 999, 957 cm-1; 1H NMR (400 MHz, CDCl3, δ) 6.07 (d, J = 6.0 Hz, 1H), 5.25 (d, J 
= 4.4 Hz, 1H), 3.74 (s, 3H), 3.36 (s, 3H), 3.33 (m, 1H), 3.23 (dd, J = 8.4, 4.4 Hz, 1H), 3.1 
(dd, J = 19.2, 5.2 Hz, 1H), 2.74 (dd, 19.2, 11.2 Hz, 1H); 13C NMR (100 MHz, CDCl3, δ) 
175.6, 168.0, 106.9, 104.7, 55.7, 52.3, 52.1, 37.94, 32.0; HRMS-DART (m/z) calculated 
for C9H13O6 [M
+] 217.0712 found: 217.0720. 
 
TBS protected tetrahydrofurofuranone 2.70: Lactone 2.69 
(1.04 g, 4.8 mmol) in THF (240 mL) was cooled to –65 ºC and 
DIBAL (2.05 mL, 11.5 mmol) was added drop-wise over 15 
min.  The reaction mixture was warmed to –50 ºC and allowed to stir for 2.5 h, at which 
time the reaction was judged complete by TLC analysis.  Et2O (80 mL) and saturated 
aqueous Rochelle’s salt (80 mL) were added and the reaction was allowed to warm to 
room temperature and then stir vigorously for 1 h.  The layers were separated and the 
organic layer was washed with saturated aqueous NaHCO3 (1 x 25 mL) and brine (1 x 25 
mL).  The three aqueous layers were each extracted with Et2O (1 x 20 mL, each).  The 
combine organic layers were dried with MgSO4 and concentrated.   
 The resulting oil (0.71 g, 3.3 mmol) was dissolved in DMF (3.25 mL) and added 
to TBSCl (0.76 g, 4.9 mmol) and imidazole (0.44 g, 6.5 mmol).  The reaction mixture 
was allowed to stir for 16 h at room temperature.  The reaction mixture was then diluted 
with EtOAc (10 mL) and H2O (10 mL), and AcOH (10 drops) was added.  The layers 
were separated and the aqueous layer was extracted with EtOAc (3 x 10 mL).  The 
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combined organic layers were dried with MgSO4 and concentrated.  The resulting crude 
yellow oil was purified on base washed silica gel (3:1 hexanes:EtOAc) to give a pure 
yellow oil (0.58 g, 48%).  Rf = 0.69 (2:1 hexanes:EtOAc); [α]D
20 = –32.5 (c 0.40, 
CH2Cl2); IR (thin film) v max 2953, 2928, 2860, 1750, 1442, 1362, 1260, 1210, 1100, 
978, 830, 775 cm-1; 1H NMR (400 MHz, CDCl3, δ) 5.85 (d, J = 5.2 Hz, 1H), 5.61 (dd, J 
= 4.8, 2.0 Hz, 1H), 5.11 (d, J = 5.2Hz, 1H), 3.73 (m, 1H), 3.72 (s, 3H), 3.35 (s, 3H), 2.51 
(ddd, J = 5.6, 7.2, 12.8 Hz, 1H), 2.06 (m, 1H), 0.87 (s, 9H), 0.10 (s, 6H); 13C NMR (100 
MHz, CDCl3, δ) 169.0, 117.1, 109.2, 104.4, 101.3, 55.6, 52.0, 40.9, 37.9, 25.9, 18.1, -4.2, 
-5.0; HRMS-DART (m/z) calcd for C15H28O6SiNa [M+Na]
+ 355.1553, found 355.1554. 
 
Weinreb amide 2.71: Methyl ester 2.70 (0.49 g, 1.46 mmol) 
was added in THF (2.9 mL) to N,O-dimethylhydroxylamine 
hydrochloride (0.22 g, 2.26 mmol) in a 25 mL Schlenk flask.  
The reaction mixture was cooled to –15 ºC and i-PrMgCl (2.6 
mL, 4.38 mmol, 1.7 M) was added dropwise over 15 min.  The reaction mixture was 
allowed to stir at –15 ºC for 1.5 h, at which time the reaction was judged complete by 
TLC analysis.  A 50% saturated aqueous solution of NH4Cl (8 mL) was added and the 
reaction was allowed to warm to room temperature with stirring.  Et2O (10 mL) was 
added and the layers were separated.  The aqueous layer was extracted with Et2O (3 x 10 
mL), and the combined organic layers dried with MgSO4 and concentrated.  The crude 
yellow oil was purified immediately on base washed silica gel (3:1 hexanes:EtOAc) to 
give a yellow oil (0.28 g, 53%).  Rf = 0.55 (1:1 hexanes:EtOAc); [α]D
20 = –51.0 (c 0.20, 
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CH2Cl2); IR (thin film) v max 2960, 2933, 2855, 1669, 1466, 1381, 1242, 1174, 1101, 
1073, 1023, 927, 836 cm-1; 1H NMR (400 MHz, CDCl3, δ) 5.81 (d, J = 5.6 Hz, 1H), 5.61 
(dd, J = 4.8, 1.6 Hz, 1H), 5.21 (d, J = 4.8 Hz, 1H), 3.68 (s, 3H), 3.34 (m, 1H) 3.33 (s, 
3H), 3.18 (s, 3H), 3.17 (m, 1H) 2.68 (ddd, J = 13.2, 8.4, 4.8 Hz, 1H), 2.18 (ddd, J = 13.6, 
9.6, 2.0 Hz, 1H), 0.86 (s, 9H), 0.09 (s, 6H); 13C NMR (100 MHz, CDCl3, δ) 169.3, 108.5, 
104.0, 101.7, 61.2, 55.3, 50.6, 42.0, 37.9, 32.5, 25.9, 18.2, -4.2, -5.0; HRMS-DART 
(m/z)  calcd for C16H31NO6SiNa [M+Na]
+ 384.1818, found 384.1811.  
 
2,4,6-triisopropylphenylsulfonyl hydrazone 2.72: Ketone 
2.48 (0.26 g, 1.4 mmol) in CH3CN (2.3 mL) was added to 2,4,6-
triisopropylbenzenesulfonyl hydrazide (0.43 g, 1.4 mmol).  The 
reaction mixture was allowed to stir 15 min at room 
temperature, and then HBF4 (3 drops) was added.  The reaction 
mixture was allowed to stir overnight at room temperature, then 
concentrated.  The resulting white solid was taken up in a minimal amount of MeOH.  
Water was added until the solution was cloudy, and the product was allowed to 
recrystallize at –20 ˚C.  The solid was filtered and dried over P2O5 overnight to give a 
white, flocculent solid (0.41 g, 64%).  Rf = 0.71 (1:1 hexanes:Et2O); [α]D
20 = +37.1 
(c 0.90, CH2Cl2); IR (thin film) v max 3228, 2962, 2928, 2869, 1560, 1476, 1324, 1168, 
915, 725, 662 cm-1; 1H NMR (400 MHz, CDCl3, δ) 7.14 (s, 2H), 7.04 (br s, 1H), 4.21 
(quint, J = 6.8 Hz, 2H), 2.90 (quint, J = 6.8 Hz, 1H), 2.23 (dd, J = 18.0, 9.2 Hz, 1H), 2.10 
(m, 1H), 1.81 (m, 1H), 1.70 (dt, J = 13.6, 3.2 Hz, 1H), 1.54 (m, 4H), 1.42 (dt, J = 13.2, 
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3.6 Hz, 1H), 1.26 (m, 18H), 1.12 (dd, J = 13.2, 5.6 Hz, 1H), 1.03 (td, J = 13.2, 4.8 Hz, 
1H), 0.86 (s, 3H), 0.85 (s, 3H), 0.82 (s, 3H); 13C NMR (100 MHz, CDCl3, δ) 170.8, 
153.1, 151.4, 123.6, 56.2, 45.3, 41.6, 34.8, 34.3, 33.6, 32.8, 30.0, 25.1, 25.0, 23.8, 21.3, 
20.8, 19.6, 19.1; HRMS-DART (m/z) calcd for C27H44N2O2SNa [M+Na]
+ 483.3021, 
found 483.3017; m.p. = 154-159 ºC (dec). 
 
Enone 2.73:  Hydrazone 2.72 (0.3 g, 0.651 mmol) in THF 
(3.25 mL) was added to a 10 mL Schlenk flask and cooled 
to –78 ºC.  nButyllithium (0.9 mL, 1.6 M Et2O, 1.43 mmol) 
was added dropwise to the reaction mixture, which was a 
deep red at the end of the addition.  This was allowed to stir at –78 ºC for 1 h, at which 
point it was warmed to 0 ºC and N2 evolution took place.  The resulting yellow reaction 
mixture was allowed to stir for 5 min at 0 ºC and then added via cannula to a solution of 
Weinreb amide (0.107 g, 0.269 mmol) in THF (3.7 mL) at –78 ºC in a 25 mL Schlenk 
flask.  The reaction mixture was warmed to –30 ºC and allowed to stir for 12 h.  The 
reaction was then treated with H2O (5 mL) and warmed to room temperature.  The 
reaction mixture was diluted with Et2O (5 mL) and the layers were separated.  The 
aqueous layer was extracted with Et2O (3 x 5 mL).  The combined organic layers were 
dried with MgSO4 and concentrated to give a viscous orange oil that was purified on base 
washed silica gel (15:1 hexanes:Et2O) to give a yellow oil (0.125 g, 99%).  Rf = 0.37 (4:1 
hexanes:Et2O); [α]D
20 = –10.4 (c 1.0, CH2Cl2); IR (thin film) v max 2929, 2855, 1743, 
1678, 1591, 1471, 1369, 1258, 1109, 1027, 961, 834, 776 cm-1; 1H NMR (400 MHz, 
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CDCl3, δ) 6.62 [6.53] (dd, J = 3.2, 2.0 Hz, 1H), 5.83 (dd, J = 5.6, 1.6 Hz, 1H), 5.61 (td, J 
= 4.4, 2.0 Hz, 1H), 5.15 [5.06] (d, J = 4.8 Hz, 1H), 3.60 (dd, J = 7.6, 4.8 Hz, 1H), 3.30 
[3.28] (s, 3H), 3.13 (m, 1H), 2.58 (m, 1H), 2.35-2.05 (m, 3H), 1.71 (qt, J = 13.6, 3.6, 
1H), 1.60-1.02 (m, 6H), 0.96 (s, 3H), 0.95 (s, 3H), 0.89 (s, 3H), 0.87 (s, 9 H), 0.09 (s, 6 
H); 13C NMR (100 MHz, CDCl3, δ) 193.9, 193.5, 156.5, 156.2, 141.9, 141.8, 109.4, 
109.1, 106.0, 105.6, 101.9, 59.5, 59.4, 55.9, 55.7, 50.9, 47.9, 47.3, 41.5, 41.1, 37.5, 34.7, 
34.5, 33.3, 33.0, 30.2, 26.7, 24.1, 21.4, 21.3, 20.1, 20.0, 18.1, 18.0, 15.5, -4.2, -5.0; 
HRMS-DART (m/z) calcd for C25H41O4Si [M-OMe]
+ 433.2798, found 433.2777. 
 
Ketone 2.74:  Enone 2.73 (66 mg, 0.14 mmol) and rhodium 
on alumina (30 mg, 5 wt%, 0.014mmol) were diluted with 
EtOAc (4.7 mL) under N2.  This was quickly transferred to a 
Parr bomb under a blanket of N2, flushed with H2 and 
pressurized to 20 atm with H2.  The reaction was allowed to vigorously stir for 18 h at 
room temperature, at which point it was filtered through celite with EtOAc (10 mL) and 
concentrated.  The crude oil was purified on base washed silica gel (15:1 hexanes:Et2O) 
to provide a clear oil (0.43 g, 65%).  Rf = 0.35 (6:1 hexanes:Et2O); [α]D
20 = +12.8 (c 
1.25, CH2Cl2); IR (thin film) v max 2951, 2922, 2858, 1736, 1703, 1456, 1367, 1246, 
1193, 1104, 1088, 996, 832 cm-1; 1H NMR (400 MHz, CDCl3, δ) 5.81 (d, J = 4.8 Hz, 
1H), 5.57 (dd, J = 4.8, 1.6 Hz, 1H), 5.21 (d, J = 5.2 Hz, 1H), 3.34 (s, 3H), 3.13 (ddd, J = 
16.4, 13.6, 8.0 Hz, 1H), 3.07 (dd, J = 7.6, 4.8 Hz, 1H), 2.54 (t, J = 8.8 Hz, 1H), 2.35 (ddd, 
J = 13.2, 8.0, 5.2 Hz, 1H), 2.16 (ddd, J = 11.2, 9.2, 1.6 Hz, 2H), 1.84 (dt, J = 11.6, 4.0 
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Hz, 1H), 1.76-1.16 (m, 8H), 1.09 (td, J = 13.6, 4.4 Hz, 1H), 0.88 (s, 3H), 0.87 (s, 9H), 
0.86 (s, 3H), 0.68 (s, 3H), 0.09 (s, 6H); 13C NMR (100 MHz, CDCl3, δ) 232.6, 109.3, 
104.8, 101.6, 63.7, 60.7, 59.3, 55.5, 44.9, 41.4, 41.0, 40.3, 37.9, 33.6, 25.9, 22.9, 22.1, 
21.2, 20.9, 20.1, 18.1, 15.0, -4.2, -5.0; HRMS-DART (m/z) calculated for C26H46O5SiNa 
[M+Na]+ 489.3012, found 489.3011  
 
1,1-Disubstituted olefin 2.83: TMSCH2MgCl was prepared 
according to the following procedure:  To magnesium (0.12 g, 
4.98 mmol) was added TMSCH2Cl (0.6 mL, 4.1 mmol) in 
Et2O (2.4 mL).  The reaction mixture was heated to reflux for 
1 h and then allowed to cool to room temperature, at which time titration showed the 
resulting solution to be 1 M (57%).  The solution was used immediately in the subsequent 
reaction. 
 To a solution of ketone 2.80 (0.019 g, 0.041 mmol) in Et2O (0.6 mL) was added 
TMSCH2MgCl (0.41 mL, 1 M Et2O, 0.41 mmol).  The reaction mixture was allowed to 
stir 16 h at room temperature at which time the reaction was treated with H2O (5 mL) and 
AcOH (5 drops).  The layers were separated and the aqueous layer was extracted with 
Et2O (3 x 2 mL), and the combined organic layers dried with MgSO4 and concentrated to 
give a clear, colorless oil (0.021 g, 93%) that did not require further purification. 
To a solution of hydroxyl silane 2.81 (12 mg, 0.022 mmol) in THF (0.6 mL) was 
added KHMDS (8 mg, 0.043 mmol) in THF (0.6 mL).  The resulting orange reaction 
mixture was allowed to stir for 15 min at room temperature.  Pyridine (14 µL, 0.17 
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mmol) and triflic anhydride (8 µL, 0.043 mmol) were then added and the resulting red 
reaction mixture was allowed to stir for 2 h, at which time the reaction was judged 
complete by TLC analysis (100% CH2Cl2).  Saturated aqueous sodium bicarbonate 
(1 mL) and Et2O (1 mL) were added and the layers separated.  The aqueous layer was 
extracted with Et2O (3 x 1 mL).  The combined organic layers were dried with MgSO4 
and concentrated to give a crude orange oil.  The crude oil was purified on base washed 
silica gel (20:1 hexanes:Et2O) to give a clear, colorless oil (7.5 mg, 75%).  Rf = 0.66 (5:1 
hexanes:Et2O); [α]D
20 = +1.1 (c 0.375, CH2Cl2); IR (thin film) v max 2947, 2923, 2856, 
2363, 2343, 1250, 1101, 988, 831 cm-1; 1H NMR (400 MHz, CDCl3, δ) 5.85 (d, J = 5.6 
Hz, 1H), 5.57 (dd, J = 5.2, 2.0 Hz, 1H), 5.09 (s, 1H), 5.03 (s, 1H), 5.01 (d, J = 4.4 Hz, 
1H), 3.34 (s, 3H), 3.12 (m, 1 H), 2.88 (td, J = 3.6, 2.0 Hz, 1H), 2.50 (ddd, J = 13.2, 8.0, 
5.6 Hz, 1H), 2.05 (dd, J = 18.0, 8.8 Hz, 1H), 1.89 (ddd, J = 12.4, 9.6, 2.4 Hz, 1H), 1.76-
0.95 (m, 9H), 0.88 (s, 9H), 0.86 (s, 6H), 0.66 (s, 3H), 0.11 (s, 3H), 0.11 (s, 3H); 13C 
NMR (100 MHz, CDCl3, δ) 143.6, 114.0, 108.9, 105.5, 101.2, 59.1, 56.4, 55.4, 53.0, 
43.3, 42.4, 41.7, 40.0, 37.5, 33.4, 26.0, 25.2, 20.9, 20.8, 20.3, 18.2, 14.0, -4.1, -4.9; 
HRMS-DART (m/z) calcd for C26H45O3Si [M-OMe]
+ 433.3138, found 433.3143. 
 
Hydrindane triflate 2.84:  Hydrindane ketone 2.48 (50 mg, 0.28 
mmol) was dissolved in THF (4.0 mL) in a round bottom flask and 
cooled to –78 °C.  LDA (0.61 mL, 0.31 mmol) was added drop-wise 
and the reaction mixture was allowed to stir at -78 °C for 15 min.  Comins reagent (0.12 
g, 0.31 mmol) in THF (0.6mL) was added and the reaction mixture was allowed to stir 
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and warm to room temperature overnight, at which point it was judged complete by TLC 
analysis.  The reaction mixture was diluted with Et2O (5 mL) and saturated aqueous 
ammonium chloride (5 mL) was added.  The layers were separated and the aqueous 
layers were extracted with diethyl ether (3 x 5 mL).  The combined organic layers were 
then washed with 5% aqueous NaOH (2 x 5 mL), dried with MgSO4, filtered and 
concentrated.  The crude orange oil was purified on a base washed silica gel column 
(20:1 hexanes:Et2O) to provide a clear oil (53 mg, 61%).  Rf = 0.35 (hexanes); [α]D
20 = –
8.2 (c 0.17, CH2Cl2); IR (thin film) v max2940, 2863, 1632, 1420, 1207, 1412, 1064, 
1036, 917, 868, 856; 1H NMR (400 MHz, CDCl3, δ) 5.59 (dd, J = 3.6, 2.0 Hz, 1H), 2.19 
(ddd, J = 14.8, 6.4, 3.2 Hz, 1H), 2.11 (ddd, J = 14.8, 11.2, 2.0 Hz, 1H), 1.66 (m, 4 H), 
1.49 (dt, J = 12.4, 3.2, 1H), 1.35 (m, 1H), 1.16 (td, J = 13.2, 4.8 Hz, 1H), 1.07 (s, 3 H), 
0.96 (s, 3H), 0.90 (s, 3H); 13C NMR (100 MHz CDCl3, δ) 159.0, 118.8 (q, J19F-13C 340 
Hz), 114.2, 57.4, 45.5, 41.4, 33.4, 32.9, 32.3, 26.6, 21.4, 19.6, 17.4; HRMS-DART (m/z) 
calcd for C12H19[M-OTf]
+ 163.1486, found 163.14868. 
 
Hydrazone 2.85:  A mixture of ketone 2.48 (0.31 g, 0.17 mmol), 
Et3N (2.06 mL, 1.48 mmol) and hydrazine hydrate (0.67 mL, 1.38 
mmol) in EtOH (5.4 mL) was heated to reflux for 16 h.  The 
reaction was then cooled to room temperature and water (25 mL) was added to produce a 
white precipitate, which increased upon cooling to 0 ºC.  The reaction mixture was then 
filtered to give a white flocculent solid (0.28 g, 84%).  1H NMR (400 MHz, CDCl3, δ) 
4.70 (br s, 2H), 2.26 (ddd, J = 18.0, 9.2, 1.6 Hz, 1H), 2.15 (quint, J = 9.2 Hz, 1H), 1.86-
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1.52 (m, 5H), 1.46 (ddt, J = 13.6, 6.4, 2.8 Hz, 1H), 1.26 (td, J = 12.8, 4.4 Hz, 1H), 1.17 
(dd, J = 13.6, 6.0 Hz, 1H), 1.09 (td, J = 13.6, 4.4 Hz, 1H), 0.96 (s, 3H), 0.90 (s, 6H). 
 
Vinyl iodide 2.86:  Triethylamine (1.8 mL, 1.30 mmol) was added to a 
solution of hydrazone 2.85 (0.28 g, 0.14 mmol) in tetrahydrofuran 
(8.5 mL).  Iodine dissolved in THF was added until a brown color 
persisted in the reaction mixture.  The reaction was allowed to stir for 5 min.  The 
reaction mixture was diluted with ether (10 mL) and washed with: 1 M HCl (2 x 5 mL); 
saturated, aqueous Na2S2O3 (2 x 5 mL); and saturated, aqueous NaHCO3 (2 x 5 mL).  The 
organic layer was then dried with MgSO4 and concentrated.  The crude reaction mixture 
was purified by silica gel chromatography (100% hexanes) to provide a pale brown oil 
(0.29 g, 70%).  1H NMR (400 MHz, CDCl3, δ) 6.15 (t, J = 2.8 Hz, 1H), 2.08 (dd, J = 9.6, 
2.4 Hz, 2H), 1.70-1.53 (m, 3H), 1.47 (ddt, J = 19.2, 12.4, 3.2, 2H), 1.16-1.05 (m, 2H), 
0.95 (s, 3H), 0.91 (s, 3H), 0.82 (s, 3H). 
 
Hydrindane stannane 2.88: tBuLi (0.18 mL, 1.9 M in pentane, 0.31 
mmol) was added dropwise to a solution of vinyl iodide 2.86 (42 mg, 
0.145 mmol) in Et2O (2.4 mL) at –78 ºC, and the reaction mixture 
was allowed to stir for 45 min.  Bu3SnCl (47 µL, 0.174 mmol) was added and the reaction 
mixture was allowed to stir and warm to room temperature over 16 h, at which point it 
was washed with saturated aqueous NH4Cl (2 x 1 mL) and saturated aqueous NaHCO3 (2 
x 1 mL) and dried with MgSO4 and concentrated.  The resulting clear oil was pumped on 
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high vacuum for 4 h and then purified via silica gel chromatography (100% hexanes) (24 
mg, 42%).  Rf = 0.9 (hexanes); [α]D
20 = +0.2 (c 5.0, CH2Cl2). IR (thin film) v max 2953, 
2920, 2843, 1461 cm-1; 1H NMR (400 MHz, CDCl3, δ) 5.88 (dd, J = 4.0, 2.0 Hz, 1H), 
2.14 (ddd, J  = 14.8, 11.6, 1.2 Hz, 1H), 2.06 (ddd, J  = 15.2, 6.4, 3.2 Hz, 1H), 1.78-1.54 
(m, 4H), 1.53-1.42 (m, 12H), 1.31 (td, J = 14.4, 7.2, 6H), 1.26-1.11 (m, 3 H), 1.10 (s, 
6H), 0.89 (td, J  = 7.6, 2.4 Hz, 9H), 0.79 (s, 3H); 13C NMR (100 MHz, CDCl3, δ) 158.9, 
139.4, 59.7, 51.1, 41.9, 38.1, 33.7, 33.2, 31.4, 31.0, 29.6, 29.4, 27.9, 27.6, 21.3, 20.5, 
19.1, 13.9, 9.9, 8.1; HRMS-DART (m/z) calcd for C20H37Sn [M-Bu]
+ 397.1917, found 
397.1915. 
 
Methyl ketone:  To a solution of Weinreb amide 2.71 (0.03 
g, 0.083 mmol) in THF (0.6 mL) at 0 ºC was added methyl 
Grignard (0.06 mL, 0.166 mmol).  The reaction mixture was 
allowed to stir at 0 ºC for 30 min at which point it was judged complete by TLC analysis.  
Saturated, aqueous ammonium chloride (0.5 mL) was added at 0 ºC, the reaction mixture 
was warmed to room temperature and extracted with ether (4 x 1 mL).  The combined 
organic layers were dried with MgSO4 and concentrated.  The pale orange oil was 
purified on base washed silica gel chromatography (3:1 hexanes:EtOAc) to provide a 
colorless oil (0.023 g 88%).  Rf = 0.33 (1:1 hexanes:Et2O); [α]D
20 = –28.2 (c 1.10, 
CH2Cl2); IR (thin film) v max 2955, 2922, 2860, 1721, 1475, 1360, 1249, 1200, 1106, 
983, 835 cm-1; 1H NMR (400 MHz, CDCl3, δ) 5.83 (d, J = 4.8 Hz, 1H), 5.57 (dd, J = 
4.8, 2.0 Hz, 1H), 5.24 (d, J = 5.2 Hz, 1H), 3.37 (s, 3H), 3.16 (m, 1H), 2.29 (ddd, J = 
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18.4, 13.6, 5.2 Hz, 1H), 2.18 (s, 3H), 2.10 (ddd, J = 11.6, 9.6, 2.0 Hz, 1H), 0.86 (s, 9H), 
0.09 (s, 6H); 13C NMR (100 MHz, CDCl3, δ) 202.9, 109.3, 104.1, 101.5, 60.4, 55.4, 40.6, 
37.8, 29.7, 25.9, 18.1, -4.2, -5.0; HRMS-DART (m/z) calcd for C15H28O5SiNa [M+Na]
+ 
339.1604, found 339.1599.   
 
Triflate 2.90: LDA (0.21 mL, 0.5 M in THF, 0.104 mmol) 
was added to a solution of methyl ketone (30 mg, 0.095 
mmol) in THF (1.0 mL) at –78 ºC.  After 15 min Comins’ 
reagent (41 mg, 0.104 mmol) was added and the reaction was allowed to stir at -78 ºC for 
16 h at which time brine (1 mL) was added and the reaction allowed to warm to room 
temperature.  The reaction mixture was diluted with Et2O and the layers were separated.  
The aqueous layer was extracted with Et2O (2 x 1 mL) and the combined organic layers 
were washed with 5% aqueous NaOH (3 x 1 mL).  The organic layer was then dried with 
MgSO4 and concentrated.  The crude orange oil was purified by a base washed silica gel 
plug (100% Et2O) followed by a base washed silica gel column (30:1 hexanes:Et2O) to 
provide the pure product as a clear oil (21 mg, 50%).  Rf = 0.45 (5:1 hexanes:Et2O); 
[α]D
20 = –25.8 (c 0.45, CH2Cl2); IR (thin film) v max 2959, 2928, 2857, 2357, 2338, 1417, 
1213, 1144, 965, 928, 830 cm-1; 1H NMR (400 MHz, CDCl3, δ) 5.92 (d, J = 5.6 Hz, 1H), 
5.61 (dd, J = 4.8, 2.4 Hz, 1H), 5.34 (s, 2H), 5.03 (d, J = 4.4 Hz, 1H), 3.37 (s, 3H), 3.22 
(m, 1 H), 3.14 (dd, J = 8.0, 4.4 Hz, 1H), 2.37 (ddd, J = 12.4, 6.8, 5.2 Hz, 1H), 1.85 (ddd, 
J = 12.4, 9.6, 2.4 Hz, 1H), 0.89 (s, 9H), 0.11(s, 6H); 13C NMR (100 MHz, CDCl3, δ) 
151.5, 118.0 (q, J19F-13C 318 Hz), 108.9, 108.3, 103.7, 100.9, 55.3, 50.2, 41.8, 36.8, 25.9, 
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13.1, -4.2, -5.0; HRMS-DART (m/z) calcd for C16H27O7SiSF3Na [M+Na]
+ 471.1097, 
found 471.1080. 
 
Stannane 2.91: Palladium dibenzylidene acetone (1.5 mg, 
0.0013 mmol), lithium chloride (5.0 mg, 0.107 mmol) and 
triphenyl arsine (1.0 mg, 0.0027 mmol) were weighed out in 
a glovebox into a vial containing a stirbar, which was sealed with a septum.  The vial was 
removed from the glovebox and THF (0.7 mL) was added, followed by hexamethyl ditin 
(14.0 µL, 0.067 mmol).  Vinyl triflate 2.90 (12.0 mg, 0.0267 mmol) was then added in 
THF (0.7 mL).  The solution was allowed to stir at room temperature for 48 h, at which 
time it was judged complete by TLC analysis.  H2O (2 mL) was added and the reaction 
mixture was extracted with Et2O (3 x 5 mL).  The combined organic layers were dried 
with MgSO4 and concentrated.  The crude oil was purified on a base washed silica gel 
column (20:1 hexanes:Et2O) to give a colorless oil (5.0 mg, 41%).  Rf = 0.44 (10:1 
hexanes: Et2O); [α]D
20 = –5.2 (c 0.267, CH2Cl2); IR (thin film) v max 2962, 2926, 2853, 
2364, 2336, 1476, 1359, 1258, 1092, 979, 830, 773 cm-1; 1H NMR (400 MHz, CDCl3, δ) 
5.87 (d, J = 5.6 Hz, 1H), 5.85 (t, J = 2.0 Hz, 1H), 5.53 (dd, J = 5.2, 3.2 Hz, 1H), 5.48 (t, 
J = 2.4 Hz, 1H), 4.84 (d, J = 4.4 Hz, 1H), 3.32 (s, 3H), 3.15 (m, 2H), 2.24 (m, 1H), 1.71 
(ddd, J = 13.2, 10.4, 3.2 Hz, 1H), 0.88 (s, 9H), 0.10 (s, 9H); 13C NMR (100 MHz, 
CDCl3, δ) 150.5, 129.1, 108.5, 105.2, 100.8, 54.5, 54.3, 44.6, 36.8 26.0, 18.2, -4.2, -5.0, -
7.6; HRMS-DART (m/z) calculated for C17H33O3SiSn [M-OMe]
+ 433.1221, found 
433.1234. 
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Lactone 2.93: To TBS protected 2.83 (5 mg, 0.011 mmol) 
dissolved in THF (0.43 mL) was added acetic acid (6 µL, 0.11 
mmol) immediately followed by TBAF (0.11 mL, 1 M in THF, 
0.11 mmol).  The reaction mixture was allowed to stir 3 h at room 
temperature, at which point it was judged complete by TLC analysis.  The reaction 
mixture was diluted with Et2O (0.5 mL) and H2O (1 mL).  The layers were separated and 
the aqueous layer was extracted with Et2O (3 x 2 mL).  The combined aqueous layers 
were dried with MgSO4, filtered and concentrated and used immediately.   
To the resulting clear oil was added PCC (5 mg, 0.022 mmol), sodium acetate (3 
mg, 0.024 mmol), celite (5 mg) and 4 Å molecular sieves (5 mg).  CH2Cl2 (0.85 mL) was 
added and the reaction mixture was allowed to stir for 12 h.  At the completion of the 
reaction, Et2O (3 mL) was added and the mixture was filtered through a base washed 
silica gel plug with Et2O and concentrated.  The crude oil was purified on base washed 
silica gel (2:1 hexanes:Et2O) to provide a clear oil (3 mg, 80%). Rf = 0.38 (1:1 
hexanes:Et2O); [α]D
20 = +4.9 (c 0.2, CH2Cl2); IR (thin film) v max 2922, 2838, 2353, 
2333, 1788, 1363, 1174, 1094, 990 cm-1; 1H NMR (400 MHz, CDCl3, δ) 6.09 (d, J = 6.0 
Hz, 1H), 5.14 (d, J = 4.0 Hz, 1H), 5.11 (s, 1H), 5.01 (d, J = 1.6 Hz, 1H), 3.36 (s, 3H), 
3.26 (m, 1H), 3.03 (dd, J = 18.8, 6.0 Hz, 1H), 2.89 (m, 1H), 2.56 (dd, J = 18.4, 10.8 Hz, 
1H), 2.03 (t, J = 9.6 Hz, 1H), 1.75-1.0 (m, 11H), 0.86 (s, 6H), 0.67 (s, 3H); 13C NMR 
(125 MHz, CDCl3, δ) 176.4, 142.8, 115.7, 107.3, 106.3, 59.1, 56.8, 55.6, 53.0, 43.6, 41.7, 
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39.9, 39.8, 33.6, 33.5, 31.8, 30.6, 25.3, 20.90, 20.87, 20.3; HRMS-DART (m/z) cald for 
C20H29O3 [M-OMe]
+ 317.2117, found 317.2118. 
Norrisolide 2.1: To methyl ether 2.93 (2.4 mg, 0.0069 mmol) 
was added water (36 µL) and TFA (0.12 mL).  The reaction 
mixture was allowed to stir for 2 h at room temperature, at which 
point the reaction was judged complete by TLC analysis.  The 
reaction mixture was then diluted with EtOAc and carefully washed with saturated 
aqueous NaHCO3 (3 x 1 mL).  The combined aqueous layers were extracted with EtOAc 
(2 x 1 mL) and the combined organic layers were dried with MgSO4, filtered and 
concentrated.  The crude oil was immediately taken on without purification. 
DMAP (0.1 mg, 0.0008 mmol) and the lactol were dissolved in CH2Cl2 (1.0 mL).  
Et3N (4.8 µL, 0.034 mmol) and acetic anhydride (3.3 µL, 0.034 mmol) were added and 
the reaction mixture was allowed to stir for 1 h at room temperature.  The reaction 
mixture was then flushed through a plug (1 cm) of base washed silica gel with CH2Cl2 (3 
mL) and then EtOAc (8 mL) and concentrated.  The crude oil was purified on a base 
washed silica gel (2:1 hexanes:Et2O) to provide norrisolide (1.0 mg, 40%).  Rf = 0.28 
(1:1 hexanes:Et2O); [α]D
20 = +3.2 (c 0.09, CH2Cl2); IR (thin film) v max 2922, 2850, 
2365, 2333, 1801, 1757, 1220, 1017 cm-1; 1H NMR (400 MHz, C6D6, δ) 6.63 (d, J = 4.0 
Hz, 1H), 5.66 (d, J = 6.4 Hz, 1H), 4.91 (s, 1H), 4.78 (s, 1H), 2.71 (ddd, J = 8.8, 3.6, 1.0 
Hz), 2.4-2.3 (m, 1H), 2.14 (dd, J = 18.4, 4.0 Hz) 1.75 (dd, J =  18.4, 10.4 Hz), 1.59 (s, 
3H), 1.45-0.6 (m, 12H), 0.86 (s, 3H), 0.80 (s, 3H), 0.47 (s, 3H); 1H NMR (400 MHz, 
CDCl3, δ) 6.45 (d, J = 3.6 Hz, 1H), 6.14 (d, J = 6.0 Hz, 1 H), 5.16 (s, 1H), 5.09 (s, 1H), 
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3.36 (m, 1H), 3.07 (dd, J = 9.6, 3.2, 1H), 2.55 (d, J = 7.2 Hz, 2H), 2.20-1.90 (m, 2H), 
2.08 (s, 3H), 1.76-1.38 (m, 6H), 1.15-0.96 (m, 4H), 0.86 (s, 3H), 0.85 (s, 3H), 0.67 (s, 
3H);  13C NMR (125 MHz, C6D6, δ) 173.3, 168.4, 143.3, 116.8, 107.0, 101.7, 58.6, 57.7, 
50.0, 44.9, 41.7, 40.0, 38.5, 33.3, 33.1, 30.4, 24.2, 21.1, 20.6, 20.3, 19.8, 14.1; HRMS-
DART (m/z) cald for C20H29O3 [M-OAc]
+ 317.2117, found 317.2108. 
Authentic:1 1H NMR (CDCl3, δ) 6.44 (d, J = 3.5 Hz, 1 H), 6.14 (d, J = 6.0 Hz, 1 H), 5.15 
(br s, 1H), 5.09 (br s, 1H), 3.36 (m, 1H), 3.07 (dd, J = 9.5, 3.5 Hz, 1H), 2.55 (d, J = 7.0 
Hz, 2H), 2.2-1.9 (m, 2 H), 2.07 (s, 3H), 1.75-1.35 (m, 6H), 1.1-0.9 (m, 4H) 0.86 (s, 3H), 
0.84 (s, 3H), 0.66 (s, 3H); 13C NMR (C6D6, δ) 173.6, 168.6, 143.5, 116.8, 107.1, 101.8, 
58.8, 57.8, 50.1, 45.1, 41.8, 40.6, 38.7, 33.5, 33.3, 30.5, 24.3, 21.2, 20.7, 20.5, 19.9, 14.2 
 
 
 
 
 
 
 
 
 
 
 
                                                 
1  Faulkner, D. J.; Hochlowski, J. E. J. Org. Chem. 1983, 48, 1141-1142. 
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Chapter 3 
Cellular Interactions of Norrisolide:  
Preliminary Investigations 
 
 
3.1 Introduction 
 As discussed in the previous chapter, our initial interest in 
norrisolide (3.1) was garnered by the reports that it induced 
irreversible Golgi fragmentation.1  The Golgi apparatus is an 
organelle that plays a pivotal role in processing, sorting and 
transporting proteins within the cell.2  However, for all of the information that is currently 
known about the Golgi, there are still details of organization and function that are 
unknown.  Uncovering specific targets of natural products that disrupt the functioning of 
the Golgi is one way to further understand this complex organelle. 
 In addition to norrisolide, there are many natural products that 
induce Golgi disruption.  One such compound is ilimaquinone (3.2), 
which has been studied in our laboratories.3  It was found that 
                                                 
1 Kim, C.; Hoang, R.; Theodorakis, E. A. Org. Lett. 1999, 1, 1295-1297. 
2 For an overview of Golgi function, see: a) Jamieson, J. D. Biochim. Biophys. Acta, 1998, 1404, 3-8. b) 
The Golgi Apparatus Mirinov, A.; Pavelka, M., Eds.; SpringerWien: NewYork, 2008. 
3  a)Bruner, S. D.; Radeke, H. S.; Tallarico, J. A.; Snapper, M. L. J. Org. Chem. 1995, 60, 1114-1115. b) 
Radeke, H. S.; Digits, C. A.; Bruner, S. D.; Snapper, M. L. J. Org. Chem. 1997, 62, 2823-2831. c) Radeke, 
H. S.; Snapper, M. L. Bioorg. Med. Chem. Lett. 1998, 6, 1227-1232. d) Radeke, H. S.; Digits, C. A.; 
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ilimaquinone inhibits S-adenosylhomocysteine hydrolase, which blocks new methylations 
in the cell.  The link between reduced methylations and the disruption of the Golgi 
apparatus was postulated to be through the Rab6 protein, which has been reported to 
function in the transport of vesicles from the nucleus of the cell to the Golgi, and also 
from the Golgi to the endoplasmic reticulum (ER).  Rab6 is methylated by S-
adenosylmethionine. Methylation is a posttranslational modification that makes proteins 
more hydrophobic, making it easier to bind with membranes or other proteins.  If new 
methylations are blocked, Rab6 would remain in the cytoplasm, along with the transport 
vesicles.  The effect of ilimaquinone can be reversed through the addition of excess S-
adenosylmethionine, which allows methylations to resume. 
Other compounds that have been reported to induce Golgi disruption include 
brefeldin A, monensin, bafilomycin, retinoic acid, okadaic acid and nocodazole (Figure 
3.1).4   
Brefeldin A (3.3) changes the morphology of the Golgi by fusing the cisternae, 
the flat stacks that make up the Golgi apparatus.  In addition to fusing the cisternae, 
brefeldin A also induces tubule formation between the Golgi and the ER by inhibition of 
guanine-nucleotide exchange factors (GEF).  GEF is an accessory protein that catalyzes 
the transformation of GDP to GTP.  GEF is bound to ADP-ribosylation factor 5 (ARF5), 
the function of which is protein transport through the ER-Golgi systems 5  ARF5 interacts 
weakly with membranes when bound to GDP; this interaction becomes strong when 
                                                                                                                                                 
Casaubon, R. L.; Snapper, M. L. Chem. Biol. 1999, 6, 639-647. e) Casaubon, R. L.; Snapper, M. L. Bioorg. 
Med. Chem. Lett. 2001, 11, 133-136. 
4 For a review on Golgi-disturbing agents, see: Dinter, A.; Berger, E. G. Histochem. Cell Biol. 1998, 109, 
571-590. 
5 Jackson, C. L.; Casanovoa, J. E. Trends Cell. Biol. 2000, 10, 60-67. 
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bound to GTP.    By inhibiting a domain common to all GEF proteins, brefeldin A shuts 
down Golgi-membrane activity. These effects on the Golgi complex are completely 
reversible within 120 minutes after removal of brefeldin A from the cell.6   
Monensin (3.4) affects the Golgi complex by inducing swelling that increases 
from the cis side to the trans side of the Golgi.  This swelling affects a number of Golgi 
functions, such as peripheral glycolsylation due to slowed trafficking within the Golgi.  
The direct mode of action is not clear, although breakdown of acidification mechanisms 
within the cell are thought to be related. 
                                                 
6 Strous, G. J.; Berger, E. G.; van Kerkhof, P.; Bosshart, H.; Berger, B.; Geuze, H. J. Biol. Cell. 1991, 71, 
25-31. 
Figure 3.1 Golgi-disrupting natural products. 
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Bafilomycin (3.5) also induces swelling in the Golgi complex, but to a much 
lesser extent than monensin.  Bafilomycin inhibits vacuolar ATPases, one of which is 
found in the Golgi apparatus.  This particular ATPase is responsible for acidifying the 
interior of the Golgi to a pH of 6.5, potentially interfering with proton translocating 
activity. 
Retinoic acid (3.6) induces a reversible change on the Golgi, which varies slightly 
depending on the cell line tested.  General effects include disappearance of cisternae and 
the appearance of vacuoles.  The mechanism of action of retinoic acid has not yet been 
elucidated; however, it has been postulated to interact with protein kinase C pathways.  
Protein kinase C is involved in regulating membranous organelles.   
Introduction of okadaic acid (3.7) into cells collapses the Golgi complex into a 
cluster of tubules and vesicles in a process that begins with swelling of the cisternae, 
followed by vesiculation.  It was also found that compounds in the Golgi were transferred 
to the ER.  These effects are reversible, although the amount of reversibility is dependent 
on the amount of time okadaic acid was incubated with the cell. 
Nocodazole (3.8) has been shown to depolymerize microtubules in an energy-
dependent process, which causes a breakdown in the structure of the Golgi apparatus and 
disrupts transport from the ER to the Golgi.  Within 90 minutes of introducing 
nocodazole into the cell the Golgi becomes vesiculated.  This effect is reversible within 
30 minutes of nocodazole being removed from the cell. 
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3.2 Previous Biological Studies with Norrisolide 
 The Theodorakis group, after completing the total synthesis of norrisolide, 
focused their efforts on identifying norrisolide’s biological target.7  An initial report in 
2004 looked at a variety of analogues (Figure 3.2) and determined which portions of the 
natural product were necessary for activity.8  Analogues tested included methyl ketone 
3.9, truncated analogues 3.10 and 3.11, t-butyl analogues 3.12 and 3.13, norrisane 
fragments 3.14 and 3.15, and hydrindane fragments 3.16 and 3.17. 
 These studies reinforced that in normal rat kidney (NRK) cells norrisolide 
produces an irreversible vesiculation of the Golgi apparatus at a concentration of 30 µM 
at 37 °C.  Compounds 3.9, 3.10 and 3.11 showed reversible fragmentation; the Golgi 
apparatus reformed when the compounds were washed out of the cells with buffer.  
Compounds lacking the hydrindane portion of the molecule (3.12, 3.13, 3.14 and 3.15) 
showed no vesiculation of the Golgi.  Introduction of 3.16 or 3.17 into the cell also failed 
to induce Golgi fragmentation.  These results lead to two conclusions.  First, the acetate 
acetal is necessary to obtain irreversible Golgi fragmentation.  Secondly, the hydrindane 
                                                 
7 Brady, T. P.; Kim, S. H.; Wen, K.; Theodorakis, E. A. Agnew. Chem. Int. Ed. 2004, 43, 739-742. 
8 Brady, T. P.; Wallace, E. K.; Kim. S. H.; Guizzunti, G.; Malhotra, V.; Theodorakis, E. A. Bioorg. Med. 
Chem. Lett. 2004, 14, 5035-5039. 
Figure 3.2 Norrisolide analogues in Theodorakis’ initial biological studies. 
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core must be bound to the norrisane side chain for there to be any activity.  It is 
postulated that the hydrindane core is needed for binding and that the acetate group is 
essential for irreversible vesiculation. 
 Following these results, the Theodorakis group made a series of fluorescent 
probes, 3.18-3.20 (Figure 3.3) to see where the compounds were localized in the cell.9  
As expected, analogue 3.19 with no hydrindane core had no effect on the Golgi 
apparatus.  Analogues 3.18 and 3.20 both reversibly vesiculated the Golgi in NRK cells 
and were found to localize on the Golgi apparatus.  To reinforce the concept that a side 
chain with an electrophilic moiety needs to be attached to the hydrindane core in order to 
produce an irreversible effect, 3.21 was synthesized and shown to induce irreversible 
Golgi fragmentation.   
 With a firmer understanding of the requirements for irreversible Golgi 
fragmentation, the Theodorakis group turned their attention to trying to isolate the 
                                                 
9 Guizzunti, G.; Brady, T. P.; Malhotra, V.; Theodorakis, E. A. J. Am. Chem. Soc. 2006, 128, 4190-4191. 
Figure 3.3 More advanced analogues of norrisolide from the Theodorakis group. 
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biological target of norrisolide.10  Biotin analogue 3.22 was synthesized, along with 3.23, 
which lacks the hydrindane core (Figure 3.4).  After incubation with NRK cells and UV 
irradiation, it was found that both 3.22 and 3.23 bound to the same proteins.  Without a 
unique interaction between 3.22 and a protein, the biological target of norrisolide could 
not be isolated.  Similar studies were done replacing the azide with epoxides, like those 
found in analogue 3.21.  However, these compounds displayed less than ten percent 
vesiculation of the Golgi apparatus, which was reversible.  The length of the biotin tether 
may be playing a role in the decreased activity of this analogue.  To eliminate any 
interference from the biotin, a radiolabeled analogue has been planned.  Incorporation of 
iodine into compound 3.21 gives 3.24, which performs 
comparably to 3.21, giving irreversible Golgi fragmentation.  
Installation of 125I would give a handle with which to isolate 
the biological target of norrisolide. 
 
 
                                                 
10 Guizzunti, G.; Brady, T. P.; Malhotra, V.; Theodorakis, E. A. Bioorg. Med. Chem. Lett. 2007, 17, 320-
325. 
Figure 3.4 Biotin compounds with aryl azides synthesized by Theodorakis. 
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3.3 Our Approach to Isolating the Biological Target of Norrisolide 
 With the data from the Theodorakis group in hand, we came to the hypothesis that 
binding of norrisolide to its biological target could have two possible modes of action.  
First, norrisolide could be acting as an acyl transfer reagent, explaining why the acetate 
group is necessary for reactivity.  Secondly, it is possible to think of the acetate acetal as 
a masked aldehyde (Scheme 3.1).  If this aldehyde is unmasked, norrisolide could form a 
Schiff base with a lysine residue.  It appears unlikely that interaction with the biological 
target could be taking place through the lactone, since many of Theodorakis’ substrates 
which contain the lactone component and do not have activity comparable to norrisolide.  
A third possibility is the elimination of the acetate group to form an oxonium ion and 
addition of a nucleophilic moiety.  
 If the second mode of action described above is operational the Schiff base could 
in turn be reduced with 3[H]-NaBH4 to form a radiolabeled norrisolide-protein complex 
which could then be isolated and characterized. 
 Reductive alkylation of proteins is a well known technique that has been reviewed 
in the literature.11  Reductive methylation with formaldehyde is the most prominent in the 
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Scheme 3.1 Possible transformation of norrisolide to an aldehyde. 
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literature, but higher aldehydes, such as glyceraldehyde, glucose, fructose or lactose have 
also been described.12,13  In addition, reports of tritium labeling of proteins using this 
technique are also well known.14  Using these techniques, it was postulated that isolation 
of a radiolabeled norrisolide-protein complex may be possible. 
 
 
3.4 Reductive Alkylation Labeling Study 
 Norrisolide and control compound 3.27, known from 
Theodorakis’ studies to produce reversible Golgi fragmentation, 
were the main compounds of interest for our reductive alkylation 
experiments.  Bovine liver extract was incubated with 
norrisolide, 3.27, a mixture of norrisolide and 3.27 (to see if there is a competition effect), 
and with no compound.  Each reaction was reduced with 3[H]-NaBH4 and initially 
purified by ion exchange chromatography. 
 As seen in Chart 3.1, the majority of radiolabeled proteins were liberated from the 
ion exchange resin during the wash with the initial zero-salt buffer.  This was confirmed 
by SDS-PAGE; only the first fraction from each reaction contained appreciable amounts 
of protein.  The first fraction of each reaction was further purified via size exclusion 
chromatography, with similar results.  Again, there was minimal separation of labeled 
proteins, as shown in Chart 3.2. 
                                                                                                                                                 
11 Means, G. E.; Feeney, R. E. Analytical Biochemistry, 1995, 224, 1-16. 
12 Acharya, A. S.; Mannin, J. M. J. Biol. Chem. 1980, 255, 1406-1412. 
13 Lee, H. S.; Sen, L. C.; Clifford, A. J.; Whitaker, J. R.; Feeney, R. E. J. Agric. Food. Chem. 1979, 27, 
1094-1098. 
14 Tack, B. F.; Cean, J.; Eilat, D.; Lorenz, P. E.; Scheechter, A. N. J. Biol. Chem. 1980, 255, 8842-8847. 
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 Each fraction displaying radioactivity from the size exclusion column was 
separately concentrated and run on SDS-PAGE.  The gel separated five protein bands 
which were identical for both the blank and the reaction containing norrisolide.  Figure 
Chart 3.2 Scintillation count of the fractions from size exclusion chromatography. 
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Chart 3.1 Scintillation count of the fractions from ion exchange chromatography. 
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3.5(a) shows the gel run from the reaction containing norrisolide.  For the reaction 
containing norrisolide there were no significant scintillation counts for any of the bands, 
however in the reaction with no added compound there was a significant scintillation 
count for band C of the gel (Figure 3.5(b)).  While this difference may not involve the 
cellular target of norrisolide, we are still interested in the identity of this protein band.  
There is a possibility that binding of norrisolide blocks a reduction in the blank reaction. 
Results of the protein sequencing of band C are forthcoming.  
 It is unusual that the sample with no compound shows an increased scintillation 
count, given that the expected outcome was an increase in the sample incubated with 
Figure 3.5 (a) SDS-PAGE gel of the reaction with norrisolide (right) and molecular 
weight standards (left).  (b) Comparison of scintillation counts of bands A-E in the 
SDS-PAGE gels of reactions with no compound and with norrisolide added. 
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norrisolide.  One possibility is that open form aldehyde 3.26 could be binding to a lysine 
residue to give 3.28 as postulated (Scheme 3.2), but instead of an intermolecular trap with 
tritide to give 3.29 (pathway a) an intramolecular trap to give 3.30 could be occurring 
(pathway b).  If hemiaminal 3.30 is formed, the opportunity for radiolabeling the 
norrisolide-protein complex would be lost.   
 
 
 
Scheme 3.2 Possible reactions of a norrisolide-Schiff base complex. 
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3.5 Other Possible Studies for Determining the Cellular Target of Norrisolide 
 One of the biggest challenges in isolating the biological target of norrisolide is 
that the interactions between the two are unknown.  As touched on in section 3.3, it is 
possible that norrisolide is acting as an acyl transfer reagent and not remaining bound to 
the protein in any way.  Repeating Theodorakis’ earlier experiments with methyl acetal 
3.31 and lactol 3.32 (Figure 3.6) and comparing the results with norrisolide would 
determine if the presence of a general acetal linkage at that center will also induce 
irreversible Golgi fragmentation.  Theodorakis’ experiments did not involve acetal 
compounds aside from norrisolide, and this may be a way to easily discern between a 
mechanism of action that is based on acetate transfer and one that is based on a 
norrisolide-protein complex. 
 If the results of the above experiment show that only norrisolide provides an 
irreversible vesiculation of the Golgi apparatus, then it is likely that norrisolide is acting 
as an acyl transfer reagent.  If this is the case, installation of a radiolabeled acetate group 
through the use of 14[C]- or 3[H]-acetic anhydride to give 3.33 or 3.34 (Figure 3.7), 
respectively could be enough allow for isolation of the biological target of norrisolide. 
O
O
Me
Me Me
O
MeO
H
3.31
O
O
Me
Me Me
O
HO
H
3.32
Figure 3.6 Related compounds to test for irreversible Golgi activity. 
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 If the initial experiment shows that 3.31 and/or 3.32 are comparable in reactivity 
to norrisolide then it can be surmised that norrisolide is binding directly to its target, 
through a Schiff base interaction or though a nucleophilic addition to an oxonium ion.  In 
this case it may be more difficult to isolate the specific target of norrisolide, based on the 
experiments we have already done.  Norrisolide with a pre-installed radiolabel would be 
ideal, however with the current synthetic route this radiolabel would have to be carried 
through several synthetic steps, which may not be practical.  An alternative that employs 
a small modification to norrisolide would be to methylate 3.31 α to the lactone and 
elaborate to the acetate acetal to provide compound 3.35 (Figure 3.8).15  If 3.35 performs 
                                                 
15 Biswas, B.; Sarkar, D.; Venkateswaran, R. V. Tetrahedron 2008, 64, 3212-3216. 
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Figure 3.8 Proposed compounds to probe norrisolide-protein interactions in the case of 
a Schiff-base mechanism. 
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the similarly to norrisolide in a cell based assay, then it would be possible to install a 
radioactive version with 14CH3-I.  Alternatively, a biotin tag could be installed at the 
same position to provide 3.36 (where n = 2-6). This approach is more risky based on the 
lack of activity the Theodorakis group saw using analogues 3.22 and 3.23; however, a 
longer tether may decrease steric interactions and restore activity. 
 
3.6 Conclusion 
 Isolation of the biological target of norrisolide could provide further insight into 
the inner workings of the Golgi apparatus, an organelle that performs many vital cellular 
functions.  Although we were not initially successful in identifying the cellular target, the 
enhancement in radiolabeling seen in the blank reaction may provide a starting point once 
the protein identification is complete, especially if it is found that this protein is involved 
in the same pathways as any of the Golgi disrupting agents described above.  In addition, 
a number of experiments to further elucidate norrisolide’s mechanism of action and 
cellular targets have been proposed. 
 
 
 
 
3-121 
3.7 Experimental and Supporting Information 
 
General Methods 
 
3[H]-NaBH4 (100 mCi/mmol) was obtained from American Radiolabeled Chemicals.  
Fresh liver samples were obtained from Research 87.  Centrifugation at 48,000 rpm was 
carried out in a Beckman L-70 Ultracentrifuge using a Type 55Ti rotor.  Tissues were 
homogenized in a Waring blender.  Protein sequencing was performed by the Harvard 
Microchemistry Laboratories.  Compound 3.27 was prepared according to literature 
procedure.106 
 
 
Preparation of Calf Liver 
 At 4 °C, fresh calf liver was cut into cubes (2 x 2 cm), rinsed with distilled water 
and homogenized with a buffer containing 4 M glucose, 100 mM PIPES, 1 mM DTT, 2 
mM EDTA, 5 µg/mL Pepstatin, 75 µg/mL PMSF, 2 µg/mL Aprotinin, and 2 µg/mL 
Leupeptin (1 g liver: 1 mL buffer).  The homogenized solution was centrifuged at 48,000 
rpm for 1.5 hr at 0 °C.  The clarified supernatant was removed and used immediately.   
 
 
 
                                                 
106 Guizzunti, G.; Brady, T. P.; Malhotra, V.; Theodorakis, E. A. J. Am. Chem. Soc. 2006, 128, 4190-4191. 
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Reductive Alkylation Labeling Study 
Four experiments were done in parallel, in the presence and absence of norrisolide 
or control compound 3.27.   
(1) Blank: Liver supernatant (66 µL) was allowed to sit for 14 hours at 4 °C, at 
which time 3[H]-NaBH4 (100 µg in 30 µL 0.01 M NaOH) was added.  The reaction 
mixture was allowed to mix for 4 hours at 4 °C. 
(2) Norrisolide: To liver supernatant (66 µL) was added norrisolide (10 µg in 
28 µL DMSO).  The reaction mixture was incubated for 14 hours at 4 °C.  3[H]-NaBH4 
(100 µg in 30 µL 0.01 M NaOH) was then added and the reaction mixture was allowed to 
mix for 4 hours at 4 °C. 
(3) Control: To liver supernatant (66 µL) was added 3.27 (900 µg in 28 µL 
DMSO).  The reaction mixture was incubated for 14 hours at 4 °C.  3[H]-NaBH4 (100 µg 
in 30 µL 0.01 M NaOH) was then added and the reaction mixture was allowed to mix for 
4 hours at 4 °C. 
(4) Norrisolide + Control: To liver supernatant (66 µL) was added norrisolide (10 
µg in 28 µL DMSO) and 3.27 (900 µg in 28 µL DMSO).  The reaction mixture was 
incubated for 14 hours at 4 °C.  3[H]-NaBH4 (100 µg in 30 µL 0.01 M NaOH) was then 
added and the reaction mixture was allowed to mix for 4 hours at 4 °C. 
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Ion-Exchange  
For each of the above reactions, the following procedure was performed.  2 mL 
DEAE Sephacel was added to a centrifuge tube and washed with buffer A (2 mM DTT, 
25 mM HEPES) (2 x 2.5 mL). The reaction mixture and buffer A (2.5 mL) were added 
and the tube was mixed thoroughly.  The tube was centrifuged at 3700 rpm for 5 minutes 
and the supernatant decanted.  Another 2.5 mL buffer A was added and centrifuged 
again.  This procedure was repeated with a 0.1 M stepped gradient of buffers with 
increasing amounts of KCl, up to 0.15 M.  Each fraction was then monitored for 
radioactivity.  The desired fractions were concentrated to 500 µL with a Millipore 
concentrator (MW cutoff 10 kD). 
 
Size Exclusion Chromatography 
The concentrated fractions from the ion exchange were loaded on to the top of a 
phenyl sepharose column (2 x 30 cm) that had been previously equilibrated with a buffer 
consisting of 25 mM HEPES, 2 mM DTT and 0.3 M KCl.  Fractions were eluted at 
approximately 1 mL/min with 3 mL fractions.  The fractions were all monitored for 
radioactivity and the desired fractions were concentrated to 250 µL using a Millipore 
concentrator (MW cutoff 10 kD). 
 
Separation of Target Proteins 
Proteins from the desired fractions of the size exclusion chromatography were 
separated by SDS-PAGE using a 10% running gel (6 x 8 cm, 30 mA).  The gel was 
3-124 
stained with Coomassie Blue to visualize protein bands.  Bands were cut out of the gel 
and counted for radioactivity. 
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